Stewart Factor DO
Academic Appointment
- Vance Lanier Chair of Neurology, Emory University School of Medicine
- Professor of Neurology, Emory University School of Medicine
Education
Degrees
- DO from New York College of Osteopathic Medicine at New York Institute of Technology
- BS from State University of New York at Stony Brook
Research
Focus
- I am director of the movement disorder program at Emory University. My primary areas of interest and research activities have been the study of movement disorder phenomenology, clinical trials in Parkinsons disease (PD), Huntingtons disease and dystonia and study of genetics, environmental exposures and biomarkers in PD. I am site PI for the Parkinsons Progression Markers Initiative (PPMI) supported by the Michael J Fox Foundation. I am currently examining in a longitudinal fashion psychiatric and cognitive outcomes in PD.
Publications
-
Management of freezing of gait - mechanism-based practical recommendations.
Nat Rev Neurol Volume: 21 Page(s): 327 - 344
06/01/2025 Authors: Tosserams A; Fasano A; Gilat M; Factor SA; Giladi N; Lewis SJG; Moreau C; Bloem BR; Nieuwboer A; Nonnekes J -
The Persistence of Dopamine Dysregulation Syndrome after Pallidal Deep Brain Stimulation in Parkinson's Disease.
Mov Disord Clin Pract
05/10/2025 Authors: David N; Factor SA; Tripathi R; Higginbotham L -
Tardive dyskinesia versus tardive syndrome. What is in a name?
Parkinsonism Relat Disord Volume: 133 Page(s): 107295
04/01/2025 Authors: Frei K; Scott A; Caroff SN; Jankovic J; Ondo W; Citrome L; Hauser R; Friedman JH; Bhidayasiri R; Sajatovic M -
The LRRK2 p.L1795F variant causes Parkinson's disease in the European population.
NPJ Parkinsons Dis Volume: 11 Page(s): 58
03/25/2025 Authors: Lange LM; Levine K; Fox SH; Marras C; Ahmed N; Kuznetsov N; Vitale D; Iwaki H; Lohmann K; Marsili L -
A possible pathway to freezing of gait in Parkinson's disease.
J Parkinsons Dis Volume: 15 Page(s): 282 - 290
03/01/2025 Authors: Factor SA; Weinshenker D; McKay JL -
Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
Neurol Ther Volume: 13 Page(s): 1747 - 1749
12/01/2024 Authors: Frank S; Anderson KE; Fernandez HH; Hauser RA; Claassen DO; Stamler D; Factor SA; Jimenez-Shahed J; Barkay H; Wilhelm A -
Prevalence and clinical features of cervical dystonia in Parkinson's disease.
Parkinsonism Relat Disord Volume: 127 Page(s): 107114
10/01/2024 Authors: Higginbotham L; Scorr LM; Parra SP; Sommerfeld B; Jinnah HA; Factor SA -
Development of a Tremor Detection Algorithm for Use in an Academic Movement Disorders Center.
Sensors (Basel) Volume: 24
07/31/2024 Authors: Saad M; Hefner S; Donovan S; Bernhard D; Tripathi R; Factor SA; Powell JM; Kwon H; Sameni R; Esper CD -
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study.
J Clin Psychopharmacol Volume: 44 Page(s): 386 - 396
07/01/2024 Authors: Hauser RA; Barkay H; Fernandez HH; Jimenez-Shahed J; Factor SA; Gross N; Marinelli L; Gordon MF; Barash S; Finkbeiner S -
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
Neurol Ther Volume: 13 Page(s): 655 - 675
06/01/2024 Authors: Frank S; Anderson KE; Fernandez HH; Hauser RA; Claassen DO; Stamler D; Factor SA; Jimenez-Shahed J; Barkay H; Wilhelm A -
Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study.
J Neurol Volume: 271 Page(s): 3554 - 3570
06/01/2024 Authors: Kassubek J; Factor SA; Balaguer E; Schwarz J; Chaudhuri KR; Isaacson SH; Wu S; Denecke Muhr C; Kulisevsky J -
Preclinical Evaluation of Novel Positron Emission Tomography (PET) Probes for Imaging Leucine-Rich Repeat Kinase 2 (LRRK2).
J Med Chem Volume: 67 Page(s): 2559 - 2569
02/22/2024 Authors: Chen Z; Chen J; Mori W; Yi Y; Rong J; Li Y; Leon ERC; Shao T; Song Z; Yamasaki T -
Impact of deep brain stimulation on gait in Parkinson disease: A kinematic study.
Gait Posture Volume: 108 Page(s): 151 - 156
02/01/2024 Authors: Tripathi R; McKay JL; Factor SA; Esper CD; Bernhard D; Testini P; Miocinovic S -
Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial.
Nat Med Volume: 30 Page(s): 606
02/01/2024 Authors: Feigin A; Evans EE; Fisher TL; Leonard JE; Smith ES; Reader A; Mishra V; Manber R; Walters KA; Kowarski L -
Classifying Tremor Dominant and Postural Instability and Gait Difficulty Subtypes of Parkinson's Disease from Full-Body Kinematics.
Sensors (Basel) Volume: 23
10/09/2023 Authors: Gong NJ; Clifford GD; Esper CD; Factor SA; McKay JL; Kwon H -
Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient?
Mov Disord Clin Pract Volume: 10 Page(s): 1399 - 1403
09/01/2023 Authors: Cotton AC; Scorr L; McDonald W; Comella C; Perlmutter JS; Goetz CG; Jankovic J; Marsh L; Factor S; Jinnah HA -
Reply: Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations.
Mov Disord Clin Pract Volume: 10 Page(s): 1235 - 1236
08/01/2023 Authors: Block CK; Patel M; Risk BB; Staikova E; Loring D; Esper CD; Scorr L; Higginbotham L; Aia P; De Long MR -
Neuromelanin-sensitive MRI correlates of cognitive and motor function in Parkinson's disease with freezing of gait.
medRxiv
07/06/2023 Authors: Huddleston DE; Chen X; Hwang K; Langley J; Tripathi R; Tucker K; McKay JL; Hu X; Factor SA -
Physiological measures and anatomical correlates of subthalamic deep brain stimulation effect on gait in Parkinson's disease.
J Neurol Sci Volume: 449 Page(s): 120647
06/15/2023 Authors: Agharazi H; Hardin EC; Flannery K; Beylergil SB; Noecker A; Kilbane C; Factor SA; McIntyre C; Shaikh AG -
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Neurol Volume: 22 Page(s): 494 - 504
06/01/2023 Authors: Furr Stimming E; Claassen DO; Kayson E; Goldstein J; Mehanna R; Zhang H; Liang GS; Haubenberger D; Huntington Study Group KINECT-HD Collaborators -
Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations.
Mov Disord Volume: 38 Page(s): 1008 - 1026
06/01/2023 Authors: Martino D; Karnik V; Bhidayasiri R; Hall DA; Hauser RA; Macerollo A; Pringsheim TM; Truong D; Factor SA; Skorvanek M -
Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson's disease.
Neurobiol Dis Volume: 179 Page(s): 106048
04/01/2023 Authors: McKay JL; Nye J; Goldstein FC; Sommerfeld B; Smith Y; Weinshenker D; Factor SA -
Patients with Cognitive Impairment in Parkinson's Disease Benefit from Deep Brain Stimulation: A Case-Control Study.
Mov Disord Clin Pract Volume: 10 Page(s): 382 - 391
03/01/2023 Authors: Block CK; Patel M; Risk BB; Staikova E; Loring D; Esper CD; Scorr L; Higginbotham L; Aia P; DeLong MR -
An Explainable Spatial-Temporal Graphical Convolutional Network to Score Freezing of Gait in Parkinsonian Patients.
Sensors (Basel) Volume: 23
02/04/2023 Authors: Kwon H; Clifford GD; Genias I; Bernhard D; Esper CD; Factor SA; McKay JL -
An explainable spatial-temporal graphical convolutional network to score freezing of gait in parkinsonian patients.
medRxiv
01/18/2023 Authors: Kwon H; Clifford GD; Genias I; Bernhard D; Esper CD; Factor SA; McKay JL -
Gait Declines Differentially in, and Improves Prediction of, People with Parkinson's Disease Converting to a Freezing of Gait Phenotype.
J Parkinsons Dis Volume: 13 Page(s): 961 - 973
01/01/2023 Authors: Virmani T; Landes RD; Pillai L; Glover A; Larson-Prior L; Prior F; Factor SA -
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
CNS Drugs Volume: 36 Page(s): 1207 - 1216
11/01/2022 Authors: Frank S; Testa C; Edmondson MC; Goldstein J; Kayson E; Leavitt BR; Oakes D; O'Neill C; Vaughan C; Whaley J -
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.
Trials Volume: 23 Page(s): 855
10/06/2022 Authors: Patterson CG; Joslin E; Gil AB; Spigle W; Nemet T; Chahine L; Christiansen CL; Melanson E; Kohrt WM; Mancini M -
Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial.
Nat Med Volume: 28 Page(s): 2183 - 2193
10/01/2022 Authors: Feigin A; Evans EE; Fisher TL; Leonard JE; Smith ES; Reader A; Mishra V; Manber R; Walters KA; Kowarski L -
Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases.
J Neurol Neurosurg Psychiatry Volume: 93 Page(s): 609 - 616
06/01/2022 Authors: Lidstone SC; Costa-Parke M; Robinson EJ; Ercoli T; Stone J; FMD GAP Study Group -
Reply to: "Letter on Discussionof Gait Research".
Mov Disord Volume: 37 Page(s): 1328
06/01/2022 Authors: Bohnen NI; Costa RM; Dauer WT; Factor SA; Giladi N; Hallett M; Lewis SJG; Nieuwboer A; Nutt JG; Takakusaki K -
Stepping up to meet the challenge of freezing of gait in Parkinson's disease.
Transl Neurodegener Volume: 11 Page(s): 23
05/01/2022 Authors: Lewis S; Factor S; Giladi N; Nieuwboer A; Nutt J; Hallett M -
Hold that pose: capturing cervical dystonia's head deviation severity from video.
Ann Clin Transl Neurol Volume: 9 Page(s): 684 - 694
05/01/2022 Authors: Zhang Z; Cisneros E; Lee HY; Vu JP; Chen Q; Benadof CN; Whitehill J; Rouzbehani R; Sy DT; Huang JS -
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
CNS Spectr Volume: 27 Page(s): 208 - 217
04/01/2022 Authors: Hauser RA; Meyer JM; Factor SA; Comella CL; Tanner CM; Xavier RM; Caroff SN; Lundt L -
Long-Term Efficacy and Safety of Deutetrabenazine in Patients with Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonist Use.
CNS Spectr Volume: 27 Page(s): 246
04/01/2022 Authors: Hauser RA; Barkay H; Fernandez HH; Factor SA; Jimenez-Shahed J; Gross N; Marinelli L; Wilhelm A; Gordon MF; Savola J-M -
Effects of Long-Term Deutetrabenazine Treatment in Patients with Tardive Dyskinesia and Underlying Psychiatric or Mood Disorders.
CNS Spectr Volume: 27 Page(s): 245 - 246
04/01/2022 Authors: Hauser RA; Barkay H; Fernandez HH; Factor SA; Jimenez-Shahed J; Gross N; Marinelli L; Wilhelm A; Gordon MF; Savola J-M -
Pseudonystagmus in progressive supranuclear palsy.
J Neurol Sci Volume: 434 Page(s): 120157
03/15/2022 Authors: Ticku H; Fotedar N; Juncos J; Factor SA; Shaikh AG -
Head tremor in cervical dystonia: Quantifying severity with computer vision.
J Neurol Sci Volume: 434 Page(s): 120154
03/15/2022 Authors: Vu JP; Cisneros E; Lee HY; Le L; Chen Q; Guo XA; Rouzbehani R; Jankovic J; Factor S; Goetz CG -
Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson's Disease.
Mov Disord Volume: 37 Page(s): 264 - 267
02/01/2022 Authors: Lewis SJG; Factor SA; Giladi N; Hallett M; Nieuwboer A; Nutt JG; Przedborski S; Papa SM; MDS Scientific Issues Committee -
Discussion of Research Priorities for Gait Disorders in Parkinson's Disease.
Mov Disord Volume: 37 Page(s): 253 - 263
02/01/2022 Authors: Bohnen NI; Costa RM; Dauer WT; Factor SA; Giladi N; Hallett M; Lewis SJG; Nieuwboer A; Nutt JG; Takakusaki K -
From null to midline: changes in head posture do not predictably change head tremor in cervical dystonia.
Dystonia Volume: 1
01/01/2022 Authors: Vu JP; Cisneros E; Zhao J; Lee HY; Jankovic J; Factor SA; Goetz CG; Barbano RL; Perlmutter JS; Jinnah HA -
Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review.
Dystonia Volume: 1
01/01/2022 Authors: Scorr LM; Cho HJ; Kilic-Berkmen G; McKay JL; Hallett M; Klein C; Baumer T; Berman BD; Feuerstein JS; Perlmutter JS -
Restless Legs Symptoms and Periodic Leg Movements in Sleep Among Patients with Parkinson's Disease.
J Parkinsons Dis Volume: 12 Page(s): 1339 - 1344
01/01/2022 Authors: Bliwise DL; Karroum EG; Greer SA; Factor SA; Trotti LM -
Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study.
Front Neurol Volume: 13 Page(s): 773999
01/01/2022 Authors: Hauser RA; Barkay H; Fernandez HH; Factor SA; Jimenez-Shahed J; Gross N; Marinelli L; Wilhelm A; Alexander J; Gordon MF -
A Multi-center Genome-wide Association Study of Cervical Dystonia.
Mov Disord Volume: 36 Page(s): 2795 - 2801
12/01/2021 Authors: Sun YV; Li C; Hui Q; Huang Y; Barbano R; Rodriguez R; Malaty IA; Reich S; Bambarger K; Holmes K -
Cerebrospinal fluid biomarkers in Parkinson's disease with freezing of gait: an exploratory analysis.
NPJ Parkinsons Dis Volume: 7 Page(s): 105
11/29/2021 Authors: Hatcher-Martin JM; McKay JL; Pybus AF; Sommerfeld B; Howell JC; Goldstein FC; Wood L; Hu WT; Factor SA -
Exploring human-genome gut-microbiome interaction in Parkinson's disease.
NPJ Parkinsons Dis Volume: 7 Page(s): 74
08/18/2021 Authors: Wallen ZD; Stone WJ; Factor SA; Molho E; Zabetian CP; Standaert DG; Payami H -
Non-motor phenotypic subgroups in adult-onset idiopathic, isolated, focal cervical dystonia.
Brain Behav Volume: 11 Page(s): e2292
08/01/2021 Authors: Wadon ME; Bailey GA; Yilmaz Z; Hubbard E; AlSaeed M; Robinson A; McLauchlan D; Barbano RL; Marsh L; Factor SA -
Telemedicine in an Academic Movement Disorders Center during COVID-19.
J Mov Disord Volume: 14 Page(s): 119 - 125
05/01/2021 Authors: Esper CD; Scorr L; Papazian S; Bartholomew D; Esper GJ; Factor SA -
Long-Term Deutetrabenazine Treatment Is Associated With Continued Improvement in Tardive Dyskinesia in the Completed 3-Year Open-Label Extension Study.
CNS Spectr Volume: 26 Page(s): 162
04/01/2021 Authors: Hauser RA; Barkay H; Fernandez HH; Factor SA; Jimenez-Shahed J; Gross N; Marinelli L; Wilhelm A; Gordon MF; Savola J-M -
Effect of Deutetrabenazine on Metabolic Parameters in the Treatment of Tardive Dyskinesia.
CNS Spectr Volume: 26 Page(s): 159 - 160
04/01/2021 Authors: Jimenez-Shahed J; Barkay H; Anderson KE; Fernandez HH; Factor SA; Hauser RA; Wieman M; Gordon MF; Savola J-M -
Clinical outcomes of globus pallidus deep brain stimulation for Parkinson disease: a comparison of intraoperative MRI- and MER-guided lead placement.
J Neurosurg Volume: 134 Page(s): 1072 - 1082
03/01/2021 Authors: Bezchlibnyk YB; Sharma VD; Naik KB; Isbaine F; Gale JT; Cheng J; Triche SD; Miocinovic S; Buetefisch CM; Willie JT -
A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson's disease 'OFF' episodes.
Expert Rev Neurother Volume: 21 Page(s): 169 - 177
02/01/2021 Authors: Caughman CY; Factor S -
Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort.
Neurology Volume: 96 Page(s): e563 - e574
01/26/2021 Authors: Shaikh AG; Beylergil SB; Scorr L; Kilic-Berkmen G; Freeman A; Klein C; Junker J; Loens S; Brggemann N; Mnchau A -
Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson's disease.
PLoS One Volume: 16 Page(s): e0252119
01/01/2021 Authors: McKay JL; Lang KC; Bong SM; Hackney ME; Factor SA; Ting LH -
Oromandibular Dystonia: A Clinical Examination of 2,020 Cases.
Front Neurol Volume: 12 Page(s): 700714
01/01/2021 Authors: Scorr LM; Factor SA; Parra SP; Kaye R; Paniello RC; Norris SA; Perlmutter JS; Bumer T; Usnich T; Berman BD -
A metabolomic study of cervical dystonia.
Parkinsonism Relat Disord Volume: 82 Page(s): 98 - 103
01/01/2021 Authors: Liu C; Scorr L; Kilic-Berkmen G; Cotton A; Factor SA; Freeman A; Tran V; Liu K; Uppal K; Jones D -
It's tricky: Rating alleviating maneuvers in cervical dystonia.
J Neurol Sci Volume: 419 Page(s): 117205
12/15/2020 Authors: Cisneros E; Stebbins GT; Chen Q; Vu JP; Benadof CN; Zhang Z; Barbano RL; Fox SH; Goetz CG; Jankovic J -
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.
J Clin Med Volume: 9
11/16/2020 Authors: Brownstein MJ; Simon NG; Long JD; Yankey J; Maibach HT; Cudkowicz M; Coffey C; Conwit RA; Lungu C; Anderson KE -
Diagnosing functional neurological disorder: seeing the whole picture.
CNS Spectr Page(s): 1 - 8
11/09/2020 Authors: Lidstone SC; Nassif W; Juncos J; Factor SA; Lang AE -
Multimodal assessment of nigrosomal degeneration in Parkinson's disease.
Parkinsonism Relat Disord Volume: 80 Page(s): 102 - 107
11/01/2020 Authors: Langley J; Huddleston DE; Crosson B; Song DD; Factor SA; Hu X -
Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's disease.
J Neurol Neurosurg Psychiatry Volume: 91 Page(s): 1210 - 1218
11/01/2020 Authors: Richardson RM; Bankiewicz KS; Christine CW; Van Laar AD; Gross RE; Lonser R; Factor SA; Kostyk SK; Kells AP; Ravina B -
Clinical outcomes of pallidal deep brain stimulation for dystonia implanted using intraoperative MRI.
J Neurosurg Volume: 133 Page(s): 1582 - 1594
11/01/2020 Authors: Sharma VD; Bezchlibnyk YB; Isbaine F; Naik KB; Cheng J; Gale JT; Miocinovic S; Buetefisch C; Factor SA; Willie JT -
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease.
Sci Adv Volume: 6
10/01/2020 Authors: Higginbotham L; Ping L; Dammer EB; Duong DM; Zhou M; Gearing M; Hurst C; Glass JD; Factor SA; Johnson ECB -
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
Ann Clin Transl Neurol Volume: 7 Page(s): 1816 - 1830
10/01/2020 Authors: Alcalay RN; Wolf P; Chiang MSR; Helesicova K; Zhang XK; Merchant K; Hutten SJ; Scherzer C; Caspell-Garcia C; Blauwendraat C -
Management of Tardive Syndrome: Medications and Surgical Treatments.
Neurotherapeutics Volume: 17 Page(s): 1694 - 1712
10/01/2020 Authors: Factor SA -
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.
JAMA Neurol Volume: 77 Page(s): 755 - 763
06/01/2020 Authors: Cudkowicz M; Chase MK; Coffey CS; Ecklund DJ; Thornell BJ; Lungu C; Mahoney K; Gutmann L; Shefner JM; Staley KJ -
139 Early Response with Valbenazine and Long-Term Symptom Reduction in Patients with Tardive Dyskinesia: Post Hoc Analysis of the KINECT 3 Study.
CNS Spectr Volume: 25 Page(s): 288 - 289
04/01/2020 Authors: Caroff SN; Lindenmayer J-P; Marder SR; Factor SA; Farahmand K; Lundt L -
151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study.
CNS Spectr Volume: 25 Page(s): 296 - 297
04/01/2020 Authors: Fernandez HH; Barkay H; Hauser RA; Factor SA; Jimenez-Shahed J; Gross N; Marinelli L; Gordon MF; Savola J-M; Anderson KE -
134 Long-Term Deutetrabenazine Treatment Is Associated with Sustained Treatment Response in Tardive Dyskinesia: Results from an Open-Label Extension Study.
CNS Spectr Volume: 25 Page(s): 284 - 285
04/01/2020 Authors: Hauser RA; Barkay H; Fernandez HH; Factor SA; Jimenez-Shahed J; Gross N; Marinelli L; Forrest Gordon M; Savola J-M; Anderson KE -
Diphasic Worsening of Freezing of Gait in Parkinson's Disease.
Mov Disord Clin Pract Volume: 7 Page(s): 325 - 328
04/01/2020 Authors: Perez Parra S; McKay JL; Factor SA -
Practical Evaluation and Management of Insomnia in Parkinson's Disease: A Review.
Mov Disord Clin Pract Volume: 7 Page(s): 250 - 266
04/01/2020 Authors: Wallace DM; Wohlgemuth WK; Trotti LM; Amara AW; Malaty IA; Factor SA; Nallu S; Wittine L; Hauser RA -
Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study.
Lancet Neurol Volume: 19 Page(s): 135 - 144
02/01/2020 Authors: Olanow CW; Factor SA; Espay AJ; Hauser RA; Shill HA; Isaacson S; Pahwa R; Leinonen M; Bhargava P; Sciarappa K -
Perception of whole-body motion during balance perturbations is impaired in Parkinson's disease and is associated with balance impairment.
Gait Posture Volume: 76 Page(s): 44 - 50
02/01/2020 Authors: Bong SM; McKay JL; Factor SA; Ting LH -
Neuromechanical Assessment of Activated vs. Resting Leg Rigidity Using the Pendulum Test Is Associated With a Fall History in People With Parkinson's Disease.
Front Hum Neurosci Volume: 14 Page(s): 602595
01/01/2020 Authors: Martino G; McKay JL; Factor SA; Ting LH -
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens.
NPJ Parkinsons Dis Volume: 6 Page(s): 11
01/01/2020 Authors: Wallen ZD; Appah M; Dean MN; Sesler CL; Factor SA; Molho E; Zabetian CP; Standaert DG; Payami H -
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
Lancet Neurol Volume: 19 Page(s): 71 - 80
01/01/2020 Authors: Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A -
Freezing of gait: understanding the complexity of an enigmatic phenomenon.
Brain Volume: 143 Page(s): 14 - 30
01/01/2020 Authors: Weiss D; Schoellmann A; Fox MD; Bohnen NI; Factor SA; Nieuwboer A; Hallett M; Lewis SJG -
Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia.
J Neurol Neurosurg Psychiatry Volume: 90 Page(s): 1317 - 1323
12/01/2019 Authors: Fernandez HH; Stamler D; Davis MD; Factor SA; Hauser RA; Jimenez-Shahed J; Ondo WG; Jarskog LF; Woods SW; Bega D -
Effect of global cognitive score on motor and quality of life outcomes after deep brain stimulation in patients with Parkinson's disease or essential tremor
Volume: 34 Page(s): S880 - S880
10/01/2019 Authors: Staikova E; Loring D; Delong M; Triche S; Buetefisch C; Esper C; Wichmann T; Scorr L; Higginbotham L; Aia P -
Machine Learning Classification of Parkinson's Disease with Neuromelanin-Sensitive MRI and Clinical Features
Volume: 86 Page(s): S179 - S179
10/01/2019 Authors: Huddleston D; Mahmoudi B; Langley J; Ellis C; Tripathi R; Lane M; Wood-Siverio C; Factor S; Hu X; Crosson B -
MRI Signatures of Iron Pathology in Parkinson's Disease and Multiple System Atrophy
Volume: 86 Page(s): S266 - S267
10/01/2019 Authors: Huddleston D; Mahmoudi B; Langley J; Ellis CA; Factor S; Hu X; Crosson B -
Lurasidone-Induced Tardive Syndrome.
Mov Disord Clin Pract Volume: 6 Page(s): 601 - 604
09/01/2019 Authors: Tripathi R; Reich SG; Scorr L; Guardiani E; Factor SA -
Recent developments in drug-induced movement disorders: a mixed picture.
Lancet Neurol Volume: 18 Page(s): 880 - 890
09/01/2019 Authors: Factor SA; Burkhard PR; Caroff S; Friedman JH; Marras C; Tinazzi M; Comella CL -
Efficacy and Safety of Apomorphine Sublingual Film for the Treatment of "OFF" Episodes in Patients with Parkinson's Disease: A Phase 3, Double-blind, Placebo-controlled Trial
Volume: 16 Page(s): 918 - 919
07/01/2019 Authors: Factor SA; Isaacson S; Hauser RA; Pahwa R; Sciarappa K; Bhargava P; Vakili G; Blum D; Navia B; Olanow CW -
Lower Limb Rigidity Is Associated with Frequent Falls in Parkinson's Disease.
Mov Disord Clin Pract Volume: 6 Page(s): 446 - 451
07/01/2019 Authors: McKay JL; Hackney ME; Factor SA; Ting LH -
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).
Parkinsonism Relat Disord Volume: 62 Page(s): 201 - 209
05/01/2019 Authors: Prakash N; Caspell-Garcia C; Coffey C; Siderowf A; Tanner CM; Kieburtz K; Mollenhauer B; Galasko D; Merchant K; Foroud T -
PD-1102: A Phase 1 study of VY-AADC01 Administered Using a Posterior Approach in Patients with Parkinson's, Disease and Motor Fluctuations
Volume: 92
04/09/2019 Authors: Van Laar A; Richardson M; Christine C; Factor S; Gross R; Kostyk S; Lonser R; de Somer M; Sedkov A; Ravina B -
Long-Term Treatment With Deutetrabenazine Is Associated With Continued Improvement in Tardive Dyskinesia (TD): Results From an Open-Label Extension Study
Volume: 92
04/09/2019 Authors: Hauser R; Barkay H; Fernandez H; Factor S; Jimenez-Shahed J; Gross N; Savola J-M; Anderson KE -
Anxiety and depression are associated with levodopa-responsive, but not levodopa-unresponsive, freezing of gait in Parkinson's disease
Volume: 92
04/09/2019 Authors: McKay J; Goldstein F; Factor S -
Levodopa Responsiveness Subtypes of Freezing of Gait: Results Using a Levodopa Test
Volume: 92
04/09/2019 Authors: Factor S; Alexander G; Sommerfeld B; Bernhard D; McKay J; Hanfelt J; John S; Goldstein F -
Deep Brain stimulation in Parkinson: Use of kinematics to study impact of DBS on gait
Volume: 92
04/09/2019 Authors: Tripathi R; Alexander G; Factor S -
Efficacy and Safety of Apomorphine Sublingual Film For the Treatment of "OFF" Episodes in Patients With Parkinson's Disease: A Phase 3, Double-Blind, Placebo-Controlled Trial
Volume: 34 Page(s): S13 - S13
04/01/2019 Authors: Factor SA; Isaacson S; Hauser RA; Pahwa R; Sciarappa K; Bhargava P; Vakili G; Blum D; Navia B; Olanow CW -
Presentation: Efficacy and Safety of Apomorphine Sublingual Film for the Treatment of "OFF" Episodes in Patients with Parkinson's Disease: A Phase 3, Double-Blind, Placebo-Controlled Trial
Volume: 34 Page(s): S1 - S1
04/01/2019 Authors: Factor SA; Isaacson S; Hauser RA; Pahwa R; Sciarappa K; Bhargava P; Vakili G; Blum D; Navia B; Olanow CW -
Self-reported physical activity levels and clinical progression in early Parkinson's disease.
Parkinsonism Relat Disord Volume: 61 Page(s): 118 - 125
04/01/2019 Authors: Amara AW; Chahine L; Seedorff N; Caspell-Garcia CJ; Coffey C; Simuni T; Parkinson's Progression Markers Initiative -
Reproducible detection of nigral iron deposition in 2 Parkinson's disease cohorts.
Mov Disord Volume: 34 Page(s): 416 - 419
03/01/2019 Authors: Langley J; He N; Huddleston DE; Chen S; Yan F; Crosson B; Factor S; Hu X -
DIAGNOSTIC CONSIDERATIONS IN EVALUATING GERIATRIC PATIENTS WITH MOVEMENT DISORDERS
Volume: 27 Page(s): S6 - S7
03/01/2019 Authors: Mack J; Marsh L; Factor SA; McDonald WM -
46 Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-label Extension Study.
CNS Spectr Volume: 24 Page(s): 201
02/01/2019 Authors: Fernandez HH; Stamler D; Davis MD; Factor SA; Hauser RA; Jimenez-Shahed J; Ondo WG; Jarskog LF; Woods SW; LeDoux MS -
45 Long-term Treatment with Deutetrabenazine Is Associated with Continued Improvement in Tardive Dyskinesia: Results from an Open-label Extension Study.
CNS Spectr Volume: 24 Page(s): 200 - 201
02/01/2019 Authors: Hauser RA; Fernandez HH; Stamler D; Davis MD; Factor SA; Jimenez-Shahed J; Ondo WG; Jarskog LF; Woods SW; LeDoux MS -
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures.
J Parkinsons Dis Volume: 9 Page(s): 665 - 679
01/01/2019 Authors: Chahine LM; Siderowf A; Barnes J; Seedorff N; Caspell-Garcia C; Simuni T; Coffey CS; Galasko D; Mollenhauer B; Arnedo V -
Therapy of Movement Disorders A Case-Based Approach Preface
Page(s): XI - XI
01/01/2019 Authors: Reich SG; Factor SA -
Therapy of Movement Disorders A Case-Based Approach
Page(s): VI - VII
01/01/2019 Authors: Reich SG; Factor SA -
Freezing of Gait can persist after an acute levodopa challenge in Parkinson's disease.
NPJ Parkinsons Dis Volume: 5 Page(s): 25
01/01/2019 Authors: Lucas McKay J; Goldstein FC; Sommerfeld B; Bernhard D; Perez Parra S; Factor SA -
Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.
Mov Disord Volume: 33 Page(s): 1769 - 1776
11/01/2018 Authors: Espay AJ; Guskey MT; Norton JC; Coate B; Vizcarra JA; Ballard C; Factor SA; Friedman JH; Lang AE; Larsen NJ -
Plasticity-related gene 3 (LPPR1) and age at diagnosis of Parkinson disease.
Neurol Genet Volume: 4 Page(s): e271
10/01/2018 Authors: Wallen ZD; Chen H; Hill-Burns EM; Factor SA; Zabetian CP; Payami H -
Deep Brain Stimulation in Parkinson: Use of Kinematics to Study Impact of DBS on Gait
Volume: 84 Page(s): S193 - S193
10/01/2018 Authors: Tripathi R; Alexander G; Wilmot G; Miocinovic S; Buetefisch C; Aia P; Scorr L; Factor S -
Deep Brain Stimulation Improves Dystonia in Classical and Atypical Pantothenate Kinase-Associated Degeneration
Volume: 84 Page(s): S100 - S100
10/01/2018 Authors: Anh-Thu NV; Hatcher-Martin JM; Scorr LM; Factor SA; Gross RE; Buetefisch CM -
Cognitive Correlates of Levodopa Unresponsive versus Responsive Freezing of Gait Subtypes
Volume: 84 Page(s): S92 - S92
10/01/2018 Authors: Goldstein F; MCkay JL; Sommerfeld B; John S; Alexander G; Factor SA -
Clinical Characteristics of Oromandibular Dystonia: A Multicenter Review of 201 Cases
Volume: 84 Page(s): S90 - S90
10/01/2018 Authors: Scorr L; Factor SA; Jinnah HA -
Anxiety and Depression Are Associated with Levodopa-Responsive Freezing of Gait in Parkinson's Disease
Volume: 84 Page(s): S202 - S202
10/01/2018 Authors: McKay JL; Goldstein FC; Factor SA -
Impaired Directional Perception of Whole Body Perturbations in People with Parkinson's Disease May Contribute to Balance Impairment
Volume: 84 Page(s): S98 - S99
10/01/2018 Authors: Bong S; McKay JL; Factor SA; Ting LH -
Lower-Limb Rigidity, but Neither Upper-Limb nor Neck Rigidity is Associated with Frequent Falls in Parkinson's Disease
Volume: 84 Page(s): S203 - S204
10/01/2018 Authors: McKay JL; Hackney ME; Factor SA; Ting LH -
A Case Series Analysis of the Effects of GPi DBS on Features of Dopamine Dysregulation Syndrome
Volume: 84 Page(s): S93 - S93
10/01/2018 Authors: Higginbotham L; Factor S -
Camptocormia: a consensus for grading on a curve.
Parkinsonism Relat Disord Volume: 52 Page(s): 6
07/01/2018 Authors: Factor SA -
High and Low Levels of an NTRK2-Driven Genetic Profile Affect Motor- and Cognition-Associated Frontal Gray Matter in Prodromal Huntington's Disease.
Brain Sci Volume: 8
06/22/2018 Authors: Ciarochi JA; Liu J; Calhoun V; Johnson H; Misiura M; Bockholt HJ; Espinoza FA; Caprihan A; Plis S; Turner JA -
VMAT2 inhibitors for the treatment of tardive dyskinesia.
J Neurol Sci Volume: 389 Page(s): 43 - 47
06/15/2018 Authors: Scorr LM; Factor SA -
Lurasidone HCL Induced Tardive Dyskinesia: Two Cases
Volume: 33 Page(s): S18 - S18
06/01/2018 Authors: Tripathi R; Scorr L; Factor S -
Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.
Mov Disord Volume: 33 Page(s): 793 - 804
05/01/2018 Authors: Houser MC; Chang J; Factor SA; Molho ES; Zabetian CP; Hill-Burns EM; Payami H; Hertzberg VS; Tansey MG -
Quantitative tremor analysis of Holmes tremor: a case series
Volume: 90
04/10/2018 Authors: Anh-Thu V; Tripathi R; Alexander G; Factor S -
A Case Series Analysis of the Effects of GPi DBS on Features of Dopamine Dysregulation Syndrome
Volume: 90
04/10/2018 Authors: Higginbotham L; Factor S -
Effects of Long-Term Valbenazine on Tardive Dyskinesia and Patient-Reported Outcomes: Results from the KINECT 4 Study
Volume: 90
04/10/2018 Authors: Factor S; Kane J; Marder S; Hauser R; Farahmand K; Jimenez R; Burke J; Siegert S; Liang G -
Long-Term Treatment With Deutetrabenazine is Associated With Continued Improvement in Tardive Dyskinesia (TD): Results From an Open-Label Extension Study
Volume: 90
04/10/2018 Authors: Hauser RA; Fernandez HH; Stamler D; Davis MD; Factor SA; Jimenez-Shahed J; Ondo WG; Jarskog LF; Woods SW; LeDoux MS -
Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-Label Extension Study
Volume: 90
04/10/2018 Authors: Fernandez HH; Stamler D; Davis MD; Factor SA; Hauser RA; Jimenez-Shahed J; Ondo WG; Jarskog LF; Woods SW; LeDoux MS -
Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia.
Neurotherapeutics Volume: 15 Page(s): 452 - 458
04/01/2018 Authors: Scorr LM; Silver MR; Hanfelt J; Sperin E; Freeman A; Jinnah HA; Factor SA -
EFFICACY AND SAFETY OF VALBENAZINE (NBI-98854) IN SUBJECTS WITH TARDIVE DYSKINESIA: RESULTS OF A LONG-TERM STUDY (KINECT 3 EXTENSION)
Volume: 46 Page(s): E35 - E35
01/01/2018 Authors: Siegert S; Factor S; Liang G; Burke J -
The role of neurotransmitters in the development of Parkinson's disease-related psychosis.
Eur J Neurol Volume: 24 Page(s): 1244 - 1254
10/01/2017 Authors: Factor SA; McDonald WM; Goldstein FC -
Phosphodiesterase 4: Rethinking cognition in Parkinson disease.
Neurology Volume: 89 Page(s): 530 - 531
08/08/2017 Authors: Jacova C; Factor SA -
Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease.
Neurobiol Aging Volume: 56 Page(s): 211.e1 - 211.e7
08/01/2017 Authors: Mata IF; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Van Deerlin VM; Ritz B; Rausch R; Factor SA; Wood-Siverio C -
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Psychiatry Volume: 4 Page(s): 595 - 604
08/01/2017 Authors: Anderson KE; Stamler D; Davis MD; Factor SA; Hauser RA; Isojrvi J; Jarskog LF; Jimenez-Shahed J; Kumar R; McEvoy JP -
Oromandibular dystonia (OMD): A Prospective, Single-Blind Trial of AbobotulinumtoxinA (AboA)
Volume: 32
06/01/2017 Authors: Factor S; Silver M; Hanfelt J; Sperine E; Scorr L; Freeman A; Jinnah H -
Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease.
Mov Disord Volume: 32 Page(s): 893 - 903
06/01/2017 Authors: Fox SH; Metman LV; Nutt JG; Brodsky M; Factor SA; Lang AE; Pope LE; Knowles N; Siffert J -
Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study.
Neurology Volume: 88 Page(s): 2003 - 2010
05/23/2017 Authors: Fernandez HH; Factor SA; Hauser RA; Jimenez-Shahed J; Ondo WG; Jarskog LF; Meltzer HY; Woods SW; Bega D; LeDoux MS -
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
Am J Psychiatry Volume: 174 Page(s): 476 - 484
05/01/2017 Authors: Hauser RA; Factor SA; Marder SR; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang GS; O'Brien CF -
In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease.
Hum Brain Mapp Volume: 38 Page(s): 2627 - 2634
05/01/2017 Authors: Huddleston DE; Langley J; Sedlacik J; Boelmans K; Factor SA; Hu XP -
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
Mov Disord Volume: 32 Page(s): 739 - 749
05/01/2017 Authors: Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP -
The "shirt collar sign" of cervical dystonia.
Int J Neurosci Volume: 127 Page(s): 466 - 468
05/01/2017 Authors: Silver MR; Hanfelt J; Factor SA -
Role of Inflammation and Immune Responses in Age-Related Neurodegeneration
Volume: 26 Page(s): 727 - 728
05/01/2017 Authors: Tansey MG; Kannarkat GT; Cook DA; Eidson LN; Cintron AF; MacPherson KP; Carr C; Caudle WM; Factor SA; Boss J -
A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned
PARKINSONISM & RELATED DISORDERS Volume: 37 Page(s): 101 - 105
04/01/2017 Authors: Pfeiffer RF; Quigley EMM; Factor S; Fernandez H; McDermott MP; Shannon K; Casaceli C; de Blieck EA; Sharma S; Gottesdiener K -
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
Neurology Volume: 88 Page(s): 152 - 159
01/10/2017 Authors: McGarry A; McDermott M; Kieburtz K; de Blieck EA; Beal F; Marder K; Ross C; Shoulson I; Gilbert P; Mallonee WM -
Psychodynamic Psychotherapy for Functional (Psychogenic) Movement Disorders.
J Mov Disord Volume: 10 Page(s): 40 - 44
01/01/2017 Authors: Sharma VD; Jones R; Factor SA -
Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future.
Front Neurol Volume: 8 Page(s): 106
01/01/2017 Authors: Rommelfanger KS; Factor SA; LaRoche S; Rosen P; Young R; Rapaport MH -
Affective Correlates of Psychosis in Parkinson's Disease.
Mov Disord Clin Pract Volume: 4 Page(s): 225 - 230
01/01/2017 Authors: Factor SA; Scullin MK; Freeman A; Bliwise DL; McDonald WM; Goldstein FC -
The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study.
J Clin Psychiatry Volume: 78 Page(s): 1344 - 1350
01/01/2017 Authors: Factor SA; Remington G; Comella CL; Correll CU; Burke J; Jimenez R; Liang GS; O'Brien CF -
LRRK2 levels in immune cells are increased in Parkinson's disease.
NPJ Parkinsons Dis Volume: 3 Page(s): 11
01/01/2017 Authors: Cook DA; Kannarkat GT; Cintron AF; Butkovich LM; Fraser KB; Chang J; Grigoryan N; Factor SA; West AB; Boss JM -
Saccades in progressive supranuclear palsy - maladapted, irregular, curved, and slow.
Mov Disord Clin Pract Volume: 4 Page(s): 671 - 681
01/01/2017 Authors: Shaikh AG; Factor SA; Juncos J -
Role of Inflammation and Immune Responses in Age-Related Neurodegeneration
Volume: 26 Page(s): 727 - 728
01/01/2017 Authors: Tansey MG; Kannarkat GT; Cook DA; Eidson LN; Cintron AF; MacPherson KP; Carr C; Caudle WM; Factor SA; Boss J -
A Comprehensive Approach to Care in Parkinson's Disease Adds Quality to the Current Gold Standard.
Mov Disord Clin Pract Volume: 4 Page(s): 743 - 749
01/01/2017 Authors: Vaughan CP; Prizer LP; Vandenberg AE; Goldstein FC; Trotti LM; Hermida AP; Factor SA -
A case of lithium-induced parkinsonism presenting with typical motor symptoms of Parkinson's disease in a bipolar patient.
Int Psychogeriatr Volume: 28 Page(s): 2101 - 2104
12/01/2016 Authors: Hermida AP; Janjua AU; Glass OM; Vaughan CP; Goldstein F; Trotti LM; Factor SA -
Propranolol therapy for Tardive dyskinesia: A retrospective examination.
Parkinsonism Relat Disord Volume: 32 Page(s): 124 - 126
11/01/2016 Authors: Hatcher-Martin JM; Armstrong KA; Scorr LM; Factor SA -
Physiology of freezing of gait.
Ann Neurol Volume: 80 Page(s): 644 - 659
11/01/2016 Authors: Snijders AH; Takakusaki K; Debu B; Lozano AM; Krishna V; Fasano A; Aziz TZ; Papa SM; Factor SA; Hallett M -
Identification of genetic modifiers of age-at-onset for familial Parkinson's disease.
Hum Mol Genet Volume: 25 Page(s): 3849 - 3862
09/01/2016 Authors: Hill-Burns EM; Ross OA; Wissemann WT; Soto-Ortolaza AI; Zareparsi S; Siuda J; Lynch T; Wszolek ZK; Silburn PA; Mellick GD -
PRESENTATION: Late-Breaking Research: A Randomized, Double-Blind, Placebo-Controlled Trial of Deutetrabenazine for the Treatment of Tardive Dyskinesia (ARM-TD)
Volume: 31 Page(s): E1 - E2
09/01/2016 Authors: Fernandez HH; Factor SA; Hauser RA; Jimenez-Shahed J; Ondo W; LeDoux MS; Shprecher D; Simuni T; Stamler D; Anderson KE -
The role of polymyography in the treatment of cervical dystonia: the authors reply.
J Neurol Volume: 263 Page(s): 1665
08/01/2016 Authors: Jinnah HA; Factor S -
Freezing of gait: A rare delayed complication of whole brain radiation.
Parkinsonism Relat Disord Volume: 29 Page(s): 129 - 130
08/01/2016 Authors: Hatcher-Martin JM; Factor SA -
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
JAMA Volume: 316 Page(s): 40 - 50
07/05/2016 Authors: Huntington Study Group; Frank S; Testa CM; Stamler D; Kayson E; Davis C; Edmondson MC; Kinel S; Leavitt B; Oakes D -
Freezing of gait that disappears: Should there be rest before rehab?
Parkinsonism Relat Disord Volume: 28 Page(s): 169 - 170
07/01/2016 Authors: Factor SA; Hatcher-Martin JM; Morse AS; Nocera JR; Revuelta GJ -
Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.
Hum Brain Mapp Volume: 37 Page(s): 2547 - 2556
07/01/2016 Authors: Langley J; Huddleston DE; Merritt M; Chen X; McMurray R; Silver M; Factor SA; Hu X -
Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary.
Neurology Volume: 86 Page(s): 2278 - 2283
06/14/2016 Authors: Factor SA; Bennett A; Hohler AD; Wang D; Miyasaki JM -
Profile of urgent care visits in movement disorders
Volume: 31 Page(s): S572 - S572
06/01/2016 Authors: Lazarus JT; Sharma VD; Scorr L; Factor S -
Clinical characteristics and natural history of oromandibular dystonia
Volume: 31 Page(s): S540 - S540
06/01/2016 Authors: Scorr L; Factor S; Jinnah H -
Comparing quality of PD care in a comprehensive clinic to specialist care
Volume: 31 Page(s): S580 - S580
06/01/2016 Authors: Factor SA; Prizer LP; Goldstein FC; Trotti L-M; Hermida A; Vaughan C -
In vivo MRI detection of Parkinson's disease associated degeneration in the lateral ventral tier of substantia nigra pars compacta
Volume: 31 Page(s): S435 - S435
06/01/2016 Authors: Huddleston DE; Langley J; Sedlacik J; Boelmans K; Factor SA; Hu X -
Propranolol therapy for tardive dyskinesia: A retrospective examination
Volume: 31 Page(s): S290 - S291
06/01/2016 Authors: Factor SA; Armstrong KA; Hatcher-Martin JM -
Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes.
J Neurol Volume: 263 Page(s): 1188 - 1194
06/01/2016 Authors: Jinnah HA; Goodmann E; Rosen AR; Evatt M; Freeman A; Factor S -
KINECT 3: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Valbenazine (NBI-98854) for Tardive Dyskinesia
Volume: 86
04/05/2016 Authors: Hauser R; Factor S; Marder S; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang G; O'Brien C -
Patient Acceptance and Potential Cost-Savings of Teleneurology in an Academic Outpatient Movement Disorders Practice
Volume: 86
04/05/2016 Authors: Hatcher-Martin J; Anderson E; Factor S -
A Phase 2 Study of Valbenazine (NBI-98854) for Treatment of Tardive Dyskinesia: KINECT 2
Volume: 86
04/05/2016 Authors: Factor S; Hauser R; Mandri D; Castro-Gayol J; Jimenez R; Siegert S; O'Brien C -
Comparing Quality of Parkinson Disease Care in a Comprehensive Clinic to Specialist Care
Volume: 86
04/05/2016 Authors: Vaughan C; Prizer L; Goldstein F; Trotti L-M; Hermida A; Factor S -
A Phase 2 Study of Valbenazine (NBI-98854) for Treatment of Tardive Dyskinesia: KINECT 2
Volume: 86
04/05/2016 Authors: Factor S; Hauser R; Mandri D; Castro-Gayol J; Jimenez R; Siegert S; O'Brien C -
A Phase 2 Study of Valbenazine (NBI-98854) for Treatment of Tardive Dyskinesia: KINECT 2
Volume: 86
04/05/2016 Authors: Factor S; Hauser R; Mandri D; Castro-Gayol J; Jimenez R; Siegert S; O'Brien C -
KINECT A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Valbenazine (NBI-98854) for Tardive Dyskinesia
Volume: 86
04/05/2016 Authors: Hauser R; Factor S; Marder S; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang G; O'Brien C -
A Phase 2 Study of Valbenazine (NBI-98854) for Treatment of Tardive Dyskinesia: KINECT 2
Volume: 86
04/05/2016 Authors: Factor S; Hauser R; Mandri D; Castro-Gayol J; Jimenez R; Siegert S; O'Brien C -
KINECT 3: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Valbenazine (NBI-98854) for Tardive Dyskinesia
Volume: 86
04/05/2016 Authors: Hauser R; Factor S; Marder S; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang G; O'Brien C -
A Phase 2 Study of Valbenazine (NBI-98854) for Treatment of Tardive Dyskinesia: KINECT 2
Volume: 86
04/05/2016 Authors: Factor S; Hauser R; Mandri D; Castro-Gayol J; Jimenez R; Siegert S; O'Brien C -
Patient Acceptance and Potential Cost-Savings of Teleneurology in an Academic Outpatient Movement Disorders Practice
Volume: 86
04/05/2016 Authors: Hatcher-Martin J; Anderson E; Factor S -
A Phase 2 Study of Valbenazine (NBI-98854) for Treatment of Tardive Dyskinesia: KINECT 2
Volume: 86
04/05/2016 Authors: Factor S; Hauser R; Mandri D; Castro-Gayol J; Jimenez R; Siegert S; O'Brien C -
Comparing Quality of Parkinson Disease Care in a Comprehensive Clinic to Specialist Care
Volume: 86
04/05/2016 Authors: Vaughan C; Prizer L; Goldstein F; Trotti L-M; Hermida A; Factor S -
Clinical Characteristics and Natural History of Oromandibular and Lingual Dystonia
Volume: 86
04/05/2016 Authors: Scorr L; Factor S; Jinnah H -
Clinical Characteristics and Natural History of Oromandibular and Lingual Dystonia
Volume: 86
04/05/2016 Authors: Scorr L; Factor S; Jinnah H -
Deep Brain Stimulation Placement Using Intraoperative MRI for Dystonia: One Year Clinical Outcomes
Volume: 86
04/05/2016 Authors: Sharma V; Naik K; Triche S; Buetefisch C; Willie J; Boulis N; Factor S; Gross R; DeLong M -
Deep Brain Stimulation Placement Using Intraoperative MRI for Dystonia: One Year Clinical Outcomes
Volume: 86
04/05/2016 Authors: Sharma V; Naik K; Triche S; Buetefisch C; Willie J; Boulis N; Factor S; Gross R; DeLong M -
Clinical Outcomes Of Deep Brain Stimulation Placement Using Intraoperative MRI for Parkinson Disease
Volume: 86
04/05/2016 Authors: Sharma V; Naik K; Buetefisch C; Triche S; Willie J; Boulis N; Factor S; Gross R; DeLong M -
Deep Brain Stimulation Placement Using Intraoperative MRI for Dystonia: One Year Clinical Outcomes
Volume: 86
04/05/2016 Authors: Sharma V; Naik K; Triche S; Buetefisch C; Willie J; Boulis N; Factor S; Gross R; DeLong M -
Deep Brain Stimulation Placement Using Intraoperative MRI for Dystonia: One Year Clinical Outcomes
Volume: 86
04/05/2016 Authors: Sharma V; Naik K; Triche S; Buetefisch C; Willie J; Boulis N; Factor S; Gross R; DeLong M -
Deep Brain Stimulation Placement Using Intraoperative MRI for Dystonia: One Year Clinical Outcomes
Volume: 86
04/05/2016 Authors: Sharma V; Naik K; Triche S; Buetefisch C; Willie J; Boulis N; Factor S; Gross R; DeLong M -
Deep Brain Stimulation Placement Using Intraoperative MRI for Dystonia: One Year Clinical Outcomes
Volume: 86
04/05/2016 Authors: Sharma V; Naik K; Triche S; Buetefisch C; Willie J; Boulis N; Factor S; Gross R; DeLong M -
Deep Brain Stimulation Placement Using Intraoperative MRI for Dystonia: One Year Clinical Outcomes
Volume: 86
04/05/2016 Authors: Sharma V; Naik K; Triche S; Buetefisch C; Willie J; Boulis N; Factor S; Gross R; DeLong M -
Clinical Outcomes Of Deep Brain Stimulation Placement Using Intraoperative MRI for Parkinson Disease
Volume: 86
04/05/2016 Authors: Sharma V; Naik K; Buetefisch C; Triche S; Willie J; Boulis N; Factor S; Gross R; DeLong M -
Clinimetric testing of the comprehensive cervical dystonia rating scale.
Mov Disord Volume: 31 Page(s): 563 - 569
04/01/2016 Authors: Comella CL; Perlmutter JS; Jinnah HA; Waliczek TA; Rosen AR; Galpern WR; Adler CA; Barbano RL; Factor SA; Goetz CG -
Potential mechanisms for low uric acid in Parkinson disease.
J Neural Transm (Vienna) Volume: 123 Page(s): 365 - 370
04/01/2016 Authors: Sampat R; Young S; Rosen A; Bernhard D; Millington D; Factor S; Jinnah HA -
A Functional Magnetic Resonance Imaging Study of Head Movements in Cervical Dystonia.
Front Neurol Volume: 7 Page(s): 201
01/01/2016 Authors: Prudente CN; Stilla R; Singh S; Buetefisch C; Evatt M; Factor SA; Freeman A; Hu XP; Hess EJ; Sathian K -
GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.
Mov Disord Volume: 31 Page(s): 95 - 102
01/01/2016 Authors: Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Ritz B; Rausch R; Factor SA; Wood-Siverio C -
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
JAMA Neurol Volume: 73 Page(s): 102 - 110
01/01/2016 Authors: Huntington Study Group PHAROS Investigators; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A -
The impact of oculomotor functioning on neuropsychological performance in Huntington disease.
J Clin Exp Neuropsychol Volume: 38 Page(s): 217 - 226
01/01/2016 Authors: Carvalho JO; Long JD; Westervelt HJ; Smith MM; Bruce JM; Kim J-I; Mills JA; Paulsen JS; PREDICT-HD Investigators And Coordinators Of The Huntington Study Group -
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.
Mov Disord Volume: 30 Page(s): 1885 - 1892
12/01/2015 Authors: Schuff N; Wu I-W; Buckley S; Foster ED; Coffey CS; Gitelman DR; Mendick S; Seibyl J; Simuni T; Zhang Y -
Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease.
Neuropsychology Volume: 29 Page(s): 949 - 960
11/01/2015 Authors: Kim J-I; Long JD; Mills JA; McCusker E; Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group -
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.
Mov Disord Volume: 30 Page(s): 1681 - 1687
10/01/2015 Authors: O'Brien CF; Jimenez R; Hauser RA; Factor SA; Burke J; Mandri D; Castro-Gayol JC -
Prefrontal cortex white matter tracts in prodromal Huntington disease.
Hum Brain Mapp Volume: 36 Page(s): 3717 - 3732
10/01/2015 Authors: Matsui JT; Vaidya JG; Wassermann D; Kim RE; Magnotta VA; Johnson HJ; Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group -
Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD.
Mov Disord Volume: 30 Page(s): 1664 - 1672
10/01/2015 Authors: Long JD; Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group -
The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease.
Mol Neurodegener Volume: 10 Page(s): 50
09/24/2015 Authors: Mata IF; Jang Y; Kim C-H; Hanna DS; Dorschner MO; Samii A; Agarwal P; Roberts JW; Klepitskaya O; Shprecher DR -
Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.
Mov Disord Volume: 30 Page(s): 1371 - 1381
09/01/2015 Authors: Simuni T; Caspell-Garcia C; Coffey C; Chahine LM; Lasch S; Oertel WH; Mayer G; Hgl B; Postuma R; Videnovic A -
Ocular palatal tremor plus dystonia - new syndromic association.
Mov Disord Clin Pract Volume: 2 Page(s): 267 - 270
09/01/2015 Authors: Shaikh AG; Ghasia FF; DeLong MR; Jinnah HA; Freeman A; Factor SA -
Movement disorders emergencies.
Curr Opin Neurol Volume: 28 Page(s): 406 - 412
08/01/2015 Authors: Munhoz RP; Scorr LM; Factor SA -
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
Ann Neurol Volume: 78 Page(s): 248 - 257
08/01/2015 Authors: Warren Olanow C; Bartus RT; Baumann TL; Factor S; Boulis N; Stacy M; Turner DA; Marks W; Larson P; Starr PA -
Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.
Parkinsonism Relat Disord Volume: 21 Page(s): 692 - 697
07/01/2015 Authors: Kelly VE; Johnson CO; McGough EL; Shumway-Cook A; Horak FB; Chung KA; Espay AJ; Revilla FJ; Devoto J; Wood-Siverio C -
A novel PANK2 gene mutation in a patient with pantothenate kinase-associated neurodegeneration
Volume: 30 Page(s): S477 - S478
06/01/2015 Authors: Hatcher-Martin JM; Rosen AR; Factor SA -
Non-tardive orofacial akathisia with dental sensory phenomenon
Volume: 30 Page(s): S285 - S285
06/01/2015 Authors: Scorr LM; Factor SA -
Adult-onset axial dystonia responds to globus pallidus deep brain stimulation
Volume: 30 Page(s): S521 - S521
06/01/2015 Authors: Shaikh AG; Mewes K; Jinnah HA; DeLong MR; Gross RE; Triche S; Freeman A; Factor SA -
Ocular palatal tremor plus dystonia - A novel syndromic entity
Volume: 30 Page(s): S521 - S521
06/01/2015 Authors: Shaikh AG; Ghasia FF; DeLong MR; Jinnah HA; Freeman A; Factor SA -
A comprehensive approach to Parkinson's disease
Volume: 30 Page(s): S187 - S187
06/01/2015 Authors: Vaughan CP; Vandenberg AE; Goldstein FC; Trotti LM; Hermida AP; Weeks ML; Factor SA -
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
Mov Disord Volume: 30 Page(s): 919 - 927
06/01/2015 Authors: Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM -
Cognitive profile of LRRK2-related Parkinson's disease.
Mov Disord Volume: 30 Page(s): 728 - 733
04/15/2015 Authors: Srivatsal S; Cholerton B; Leverenz JB; Wszolek ZK; Uitti RJ; Dickson DW; Weintraub D; Trojanowski JQ; Van Deerlin VM; Quinn JF -
Temporal profile of improvement of tardive dystonia after globus pallidus deep brain stimulation.
Parkinsonism Relat Disord Volume: 21 Page(s): 116 - 119
02/01/2015 Authors: Shaikh AG; Mewes K; DeLong MR; Gross RE; Triche SD; Jinnah HA; Boulis N; Willie JT; Freeman A; Alexander GE -
Diagnosis and treatment of dystonia.
Neurol Clin Volume: 33 Page(s): 77 - 100
02/01/2015 Authors: Jinnah HA; Factor SA -
The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study.
Mov Disord Volume: 30 Page(s): 278 - 283
02/01/2015 Authors: Sharp ME; Caccappolo E; Mejia-Santana H; Tang M-X; Rosado L; Orbe Reilly M; Ruiz D; Louis ED; Comella C; Nance M -
Sleep correlates of trait executive function and memory in Parkinson's disease.
J Parkinsons Dis Volume: 5 Page(s): 49 - 54
01/01/2015 Authors: Scullin MK; Fairley JA; Trotti LM; Goldstein FC; Factor SA; Bliwise DL -
Common Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson's Disease: An Observational and Case-Control Study.
NPJ Parkinsons Dis Volume: 1 Page(s): 15002-
01/01/2015 Authors: Kannarkat GT; Cook DA; Lee J-K; Chang J; Chung J; Sandy E; Paul KC; Ritz B; Bronstein J; Factor SA -
Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden.
J Int Neuropsychol Soc Volume: 21 Page(s): 8 - 21
01/01/2015 Authors: Musso M; Westervelt HJ; Long JD; Morgan E; Woods SP; Smith MM; Lu W; Paulsen JS; PREDICT-HD Investigators of the Huntington Study Group -
Cognitive correlates of hallucinations and delusions in Parkinson's disease.
J Neurol Sci Volume: 347 Page(s): 316 - 321
12/15/2014 Authors: Factor SA; Scullin MK; Sollinger AB; Land JO; Wood-Siverio C; Zanders L; Freeman A; Bliwise DL; McDonald WM; Goldstein FC -
Freezing of gait subtypes have different cognitive correlates in Parkinson's disease.
Parkinsonism Relat Disord Volume: 20 Page(s): 1359 - 1364
12/01/2014 Authors: Factor SA; Scullin MK; Sollinger AB; Land JO; Wood-Siverio C; Zanders L; Freeman A; Bliwise DL; Goldstein FC -
Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach.
Magn Reson Imaging Volume: 32 Page(s): 1301 - 1306
12/01/2014 Authors: Chen X; Huddleston DE; Langley J; Ahn S; Barnum CJ; Factor SA; Levey AI; Hu X -
Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection.
Parkinsonism Relat Disord Volume: 20 Page(s): 1171 - 1176
11/01/2014 Authors: Hauser RA; Isaacson S; Clinch T; Tigan/Apokyn Study Investigators -
Glutamate receptor gene GRIN2A, coffee, and Parkinson disease.
PLoS Genet Volume: 10 Page(s): e1004774
11/01/2014 Authors: Hamza TH; Hill-Burns EM; Scott WK; Vance JM; Factor SA; Zabetian CP; Payami H -
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
JAMA Neurol Volume: 71 Page(s): 1405 - 1412
11/01/2014 Authors: Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Hurtig HI; Van Deerlin VM; Ritz B; Rausch R; Rhodes SL; Factor SA -
Globus pallidus deep brain stimulation for adult-onset axial dystonia.
Parkinsonism Relat Disord Volume: 20 Page(s): 1279 - 1282
11/01/2014 Authors: Shaikh AG; Mewes K; Jinnah HA; DeLong MR; Gross RE; Triche S; Freeman A; Factor SA -
Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine.
Neurology Volume: 83 Page(s): 1388 - 1389
10/07/2014 Authors: Factor SA; Jankovic J -
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Nat Genet Volume: 46 Page(s): 989 - 993
09/01/2014 Authors: Nalls MA; Pankratz N; Lill CM; Do CB; Hernandez DG; Saad M; DeStefano AL; Kara E; Bras J; Sharma M -
People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.
Mov Disord Volume: 29 Page(s): 1258 - 1264
09/01/2014 Authors: Burdick DJ; Cholerton B; Watson GS; Siderowf A; Trojanowski JQ; Weintraub D; Ritz B; Rhodes SL; Rausch R; Factor SA -
Peptidoglycan recognition protein genes and risk of Parkinson's disease.
Mov Disord Volume: 29 Page(s): 1171 - 1180
08/01/2014 Authors: Goldman SM; Kamel F; Ross GW; Jewell SA; Marras C; Hoppin JA; Umbach DM; Bhudhikanok GS; Meng C; Korell M -
Internal consistency of the University of Michigan RBD Questionnaire.
J Neurol Volume: 261 Page(s): 1439 - 1441
07/01/2014 Authors: Bliwise DL; Scullin MK; Factor SA -
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
Parkinsonism Relat Disord Volume: 20 Page(s): 644 - 646
06/01/2014 Authors: Moonen AJH; Wijers A; Leentjens AFG; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R -
An F-FDG PET study of cervical muscle in parkinsonian anterocollis.
J Neurol Sci Volume: 340 Page(s): 174 - 177
05/15/2014 Authors: Revuelta GJ; Montilla J; Benatar M; Freeman A; Wichmann T; Jinnah HA; Delong MR; Factor SA -
Reliability and validity of the revised TWSTRS psychiatric module (TWSTRS-PSYCH) of the comprehensive cervical dystonia rating scale (CCDRS)
Volume: 29 Page(s): S180 - S181
05/01/2014 Authors: Zurowski MJ; McDonald W; Comella CL; Perlmutter JS; Jinnah HA; Factor S; Waliczek TA; Rosen AR; Galpern W; Goetz CG -
Convergent validity of the revised motor and psychiatric TWSTRS modules of the comprehensive cervical dystonia rating scale (CCDRS)
Volume: 29 Page(s): S494 - S494
05/01/2014 Authors: Comella CL; Perlmutter JS; Jinnah HA; Factor S; Waliczek TA; Rosen AR; Galpern W; Goetz CG; Marsh L; Jankovic J -
Distribution specific improvement of tardive dystonia after globus pallidus DBS implant
Volume: 29 Page(s): S465 - S465
05/01/2014 Authors: Shaikh AG; Jinnah HA; Mewes K; DeLong MR; Triche SD; Freeman A; Alexander G; Aia P; Buetefisch C; Esper CD -
Kevin Delgado Barron, MD (1929-2013) IN MEMORIAM
NEUROLOGY Volume: 82 Page(s): 912 - 913
03/18/2014 Authors: Bernardini GL; Factor S; Lava N; Molho E; Ritaccio AL -
Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis.
Hum Brain Mapp Volume: 35 Page(s): 792 - 809
03/01/2014 Authors: Younes L; Ratnanather JT; Brown T; Aylward E; Nopoulos P; Johnson H; Magnotta VA; Paulsen JS; Margolis RL; Albin RL -
Tracking motor impairments in the progression of Huntington's disease.
Mov Disord Volume: 29 Page(s): 311 - 319
03/01/2014 Authors: Long JD; Paulsen JS; Marder K; Zhang Y; Kim J-I; Mills JA; Researchers of the PREDICT-HD Huntington's Study Group -
Identification of a novel Parkinson's disease locus via stratified genome-wide association study.
BMC Genomics Volume: 15 Page(s): 118
02/10/2014 Authors: Hill-Burns EM; Wissemann WT; Hamza TH; Factor SA; Zabetian CP; Payami H -
A Neurodegenerative Disease Sleep Questionnaire: principal component analysis in Parkinson's disease.
J Neurol Sci Volume: 336 Page(s): 243 - 246
01/15/2014 Authors: Scullin MK; Harrison TL; Factor SA; Bliwise DL -
Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic.
Tremor Other Hyperkinet Mov (N Y) Volume: 4 Page(s): 266
01/01/2014 Authors: Zutshi D; Cloud LJ; Factor SA -
Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.
JAMA Neurol Volume: 71 Page(s): 62 - 67
01/01/2014 Authors: Alcalay RN; Caccappolo E; Mejia-Santana H; Tang MX; Rosado L; Orbe Reilly M; Ruiz D; Louis ED; Comella CL; Nance MA -
Promise of pharmacogenomics for drug discovery, treatment and prevention of Parkinson's disease. A perspective.
Neurotherapeutics Volume: 11 Page(s): 111 - 116
01/01/2014 Authors: Payami H; Factor SA -
Tardive dyskinesia: therapeutic options for an increasingly common disorder.
Neurotherapeutics Volume: 11 Page(s): 166 - 176
01/01/2014 Authors: Cloud LJ; Zutshi D; Factor SA -
Editorial: Neurotherapeutics of movement disorders.
Neurotherapeutics Volume: 11 Page(s): 3 - 5
01/01/2014 Authors: Factor SA; Jankovic J -
Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
Front Aging Neurosci Volume: 6 Page(s): 78
01/01/2014 Authors: Paulsen JS; Long JD; Johnson HJ; Aylward EH; Ross CA; Williams JK; Nance MA; Erwin CJ; Westervelt HJ; Harrington DL -
How long does it take to diagnose cervical dystonia?
J Neurol Sci Volume: 335 Page(s): 72 - 74
12/15/2013 Authors: Tiderington E; Goodman EM; Rosen AR; Hapner ER; Johns MM; Evatt ML; Freeman A; Factor S; Jinnah HA -
A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease.
Pharmacogenomics J Volume: 13 Page(s): 530 - 537
12/01/2013 Authors: Hill-Burns EM; Singh N; Ganguly P; Hamza TH; Montimurro J; Kay DM; Yearout D; Sheehan P; Frodey K; McLear JA -
Association of Parkinson disease with structural and regulatory variants in the HLA region.
Am J Hum Genet Volume: 93 Page(s): 984 - 993
11/07/2013 Authors: Wissemann WT; Hill-Burns EM; Zabetian CP; Factor SA; Patsopoulos N; Hoglund B; Holcomb C; Donahue RJ; Thomson G; Erlich H -
Sleep and impulsivity in Parkinson's disease.
Parkinsonism Relat Disord Volume: 19 Page(s): 991 - 994
11/01/2013 Authors: Scullin MK; Sollinger AB; Land J; Wood-Siverio C; Zanders L; Lee R; Freeman A; Goldstein FC; Bliwise DL; Factor SA -
Freezing of Gait in Parkinson's Disease Is Related to Executive and Perceptual Dysfunction
Volume: 74 Page(s): S43 - S43
10/01/2013 Authors: Factor SA; Scullin MK; Sollinger AB; Land J; Wood-Siverio C; Zanders L; Lee R; Freeman A; Bliwise DL; Goldstein FC -
Anxiety and Depression Are Co-Morbid Features of Psychosis in Parkinson's Disease
Volume: 74 Page(s): S47 - S48
10/01/2013 Authors: Goldstein FC; Scullin MK; Sollinger AB; Land J; Wood-Siverio C; Zanders L; Lee R; Freeman A; Bliwise DL; McDonald W -
Secondary blepharospasm associated with structural lesions of the brain.
J Neurol Sci Volume: 331 Page(s): 98 - 101
08/15/2013 Authors: Khooshnoodi MA; Factor SA; Jinnah HA -
Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia.
Parkinsonism Relat Disord Volume: 19 Page(s): 758 - 760
08/01/2013 Authors: Silver M; Factor SA -
The focal dystonias: current views and challenges for future research.
Mov Disord Volume: 28 Page(s): 926 - 943
06/15/2013 Authors: Jinnah HA; Berardelli A; Comella C; Defazio G; Delong MR; Factor S; Galpern WR; Hallett M; Ludlow CL; Perlmutter JS -
Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.
Mov Disord Volume: 28 Page(s): 817 - 820
06/01/2013 Authors: Factor SA; Wolski K; Togasaki DM; Huyck S; Cantillon M; Ho TW; Hauser RA; Pourcher E -
Tibial bone lead, but not serum polychlorinated biphenyl, concentrations are associated with neurocognitive deficits in former capacitor workers.
J Occup Environ Med Volume: 55 Page(s): 552 - 562
05/01/2013 Authors: Seegal RF; Fitzgerald EF; McCaffrey RJ; Shrestha S; Hills EA; Wolff MS; Haase RF; Todd AC; Parsons PJ; Molho ES -
Mutations in GNAL cause primary torsion dystonia.
Nat Genet Volume: 45 Page(s): 88 - 92
01/01/2013 Authors: Fuchs T; Saunders-Pullman R; Masuho I; Luciano MS; Raymond D; Factor S; Lang AE; Liang T-W; Trosch RM; White S -
Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.
J Huntingtons Dis Volume: 2 Page(s): 477 - 489
01/01/2013 Authors: Aylward EH; Harrington DL; Mills JA; Nopoulos PC; Ross CA; Long JD; Liu D; Westervelt HK; Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group -
Daytime REM sleep in Parkinson's disease.
Parkinsonism Relat Disord Volume: 19 Page(s): 101 - 103
01/01/2013 Authors: Bliwise DL; Trotti LM; Juncos JJ; Factor SA; Freeman A; Rye DB -
Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort.
Mov Disord Volume: 27 Page(s): 1797 - 1800
12/01/2012 Authors: Cloud LJ; Rosenblatt A; Margolis RL; Ross CA; Pillai JA; Corey-Bloom J; Tully HM; Bird T; Panegyres PK; Nichter CA -
Propranolol therapy for tardive dyskinesia revisited.
Mov Disord Volume: 27 Page(s): 1703
11/01/2012 Authors: Factor SA -
Non-human primate FOG develops with advanced parkinsonism induced by MPTP Treatment.
Exp Neurol Volume: 237 Page(s): 464 - 469
10/01/2012 Authors: Revuelta GJ; Uthayathas S; Wahlquist AE; Factor SA; Papa SM -
Development of the Huntington disease work function scale.
J Occup Environ Med Volume: 54 Page(s): 1300 - 1308
10/01/2012 Authors: Brossman B; Williams JK; Downing N; Mills JA; Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group -
Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class.
Mov Disord Volume: 27 Page(s): 1118 - 1124
08/01/2012 Authors: Bliwise DL; Trotti LM; Wilson AG; Greer SA; Wood-Siverio C; Juncos JJ; Factor SA; Freeman A; Rye DB -
8OHdG as a marker for Huntington disease progression.
Neurobiol Dis Volume: 46 Page(s): 625 - 634
06/01/2012 Authors: Long JD; Matson WR; Juhl AR; Leavitt BR; Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group -
Cognitive domains that predict time to diagnosis in prodromal Huntington disease.
J Neurol Neurosurg Psychiatry Volume: 83 Page(s): 612 - 619
06/01/2012 Authors: Harrington DL; Smith MM; Zhang Y; Carlozzi NE; Paulsen JS; PREDICT-HD Investigators of the Huntington Study Group -
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.
Neurology Volume: 78 Page(s): 1434 - 1440
05/01/2012 Authors: Alcalay RN; Caccappolo E; Mejia-Santana H; Tang M-X; Rosado L; Orbe Reilly M; Ruiz D; Ross B; Verbitsky M; Kisselev S -
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
Neurology Volume: 78 Page(s): 1229 - 1236
04/17/2012 Authors: Richard IH; McDermott MP; Kurlan R; Lyness JM; Como PG; Pearson N; Factor SA; Juncos J; Serrano Ramos C; Brodsky M -
Clinical subtypes of anterocollis in parkinsonian syndromes.
J Neurol Sci Volume: 315 Page(s): 100 - 103
04/15/2012 Authors: Revuelta GJ; Benatar M; Freeman A; Wichmann T; Jinnah HA; DeLong MR; Factor SA -
Estimating the Cumulative Risk of PD in Carriers of Parkin Mutations: The CORE-PD Study
Volume: 78
04/01/2012 Authors: Marder K; Tang M-X; Alcalay R; Rosado L; Mejia-Santana H; Caccappolo E; Ruiz D; Orbe-Reilly M; Ross B; Louis E -
Clinical and Genetic Characteristics of Participants with Juvenile PD: The CORE-PD Study
Volume: 78
04/01/2012 Authors: Alcalay R; Rosado L; Mejia-Santana H; Orbe-Reilly M; Caccappolo E; Tang M; Ruiz D; Ross B; Verbitsky M; Kisselev S -
Reversibility of Tardive Syndromes
Volume: 78
04/01/2012 Authors: Zutshi D; Cloud L; Factor S -
Clinical and Genetic Characteristics of Participants with Juvenile PD: The CORE-PD Study
Volume: 78
04/01/2012 Authors: Alcalay R; Rosado L; Mejia-Santana H; Orbe-Reilly M; Caccappolo E; Tang M; Ruiz D; Ross B; Verbitsky M; Kisselev S -
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.
Neurology Volume: 78 Page(s): 690 - 695
03/06/2012 Authors: Lee J-M; Ramos EM; Lee J-H; Gillis T; Mysore JS; Hayden MR; Warby SC; Morrison P; Nance M; Ross CA -
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
Ann Neurol Volume: 71 Page(s): 370 - 384
03/01/2012 Authors: Pankratz N; Beecham GW; DeStefano AL; Dawson TM; Doheny KF; Factor SA; Hamza TH; Hung AY; Hyman BT; Ivinson AJ -
BEDPARTNER REPORTED DREAM ENACTMENT BEHAVIOR MEASURED WITH THE UNIVERSITY OF MICHIGAN RBD QUESTIONNAIRE (UMRBDQ) CORRELATES WITH DAYTIME ALERTNESS INDEPENDENTLY FROM MOTOR DISABILITY IN PARKINSON'S DISEASE (PD)
Volume: 35 Page(s): A438 - A438
01/01/2012 Authors: Bliwise DL; Trotti L; Juncos J; Factor SA; Wilson A; Greer S; Rye DB -
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.
PLoS Genet Volume: 8 Page(s): e1002548
01/01/2012 Authors: Lill CM; Roehr JT; McQueen MB; Kavvoura FK; Bagade S; Schjeide B-MM; Schjeide LM; Meissner E; Zauft U; Allen NC -
FURTHER EVIDENCE OF A NARCOLEPTIC PHENOTYPE IN PARKINSON'S DISEASE (PD)
Volume: 35 Page(s): A280 - A280
01/01/2012 Authors: Bliwise DL; Trotti L; Juncos J; Factor SA; Wilson A; Greer S; Rye DB -
Head injury, -synuclein Rep1, and Parkinson's disease.
Ann Neurol Volume: 71 Page(s): 40 - 48
01/01/2012 Authors: Goldman SM; Kamel F; Ross GW; Jewell SA; Bhudhikanok GS; Umbach D; Marras C; Hauser RA; Jankovic J; Factor SA -
Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.
Neuropsychopharmacology Volume: 37 Page(s): 213 - 246
01/01/2012 Authors: Smith Y; Wichmann T; Factor SA; DeLong MR -
The Parkinson Progression Marker Initiative (PPMI).
Prog Neurobiol Volume: 95 Page(s): 629 - 635
12/01/2011 Authors: Parkinson Progression Marker Initiative -
Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease.
Mov Disord Volume: 26 Page(s): 2190 - 2195
10/01/2011 Authors: Factor SA; Steenland NK; Higgins DS; Molho ES; Kay DM; Montimurro J; Rosen AR; Zabetian CP; Payami H -
-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease.
Neurotoxicology Volume: 32 Page(s): 640 - 645
10/01/2011 Authors: Richardson JR; Roy A; Shalat SL; Buckley B; Winnik B; Gearing M; Levey AI; Factor SA; O'Suilleabhain P; German DC -
An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease.
Eur J Neurol Volume: 18 Page(s): e107 - e108
09/01/2011 Authors: Hill-Burns EM; Hamza TH; Zabetian CP; Factor SA; Payami H -
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee.
PLoS Genet Volume: 7 Page(s): e1002237
08/01/2011 Authors: Hamza TH; Chen H; Hill-Burns EM; Rhodes SL; Montimurro J; Kay DM; Tenesa A; Kusel VI; Sheehan P; Eaaswarkhanth M -
Of monkeys and men: analysis of the phase 2 double-blind, sham-surgery controlled, randomized trial of AAV2-neurturin gene therapy for Parkinson's disease.
Curr Neurol Neurosci Rep Volume: 11 Page(s): 345 - 348
08/01/2011 Authors: Huddleston DE; Factor SA -
Safety and Feasibility of Intranigral and Intraputaminal CERE-120 (AAV2-Neurturin) Administration in Parkinson's Disease
Volume: 77 Page(s): 200 - 200
07/01/2011 Authors: Siffert J; Stacy M; Turner D; Tagliati M; Alterman R; Factor S; Boulis N; Olanow CW; Lang A; Lozano A -
Tardive dyskinesia.
Curr Treat Options Neurol Volume: 13 Page(s): 231 - 241
06/01/2011 Authors: Aia PG; Revuelta GJ; Cloud LJ; Factor SA -
Movement disorders emergencies Part 2: hyperkinetic disorders.
Arch Neurol Volume: 68 Page(s): 719 - 724
06/01/2011 Authors: Robottom BJ; Factor SA; Weiner WJ -
Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis.
J Neurol Neurosurg Psychiatry Volume: 82 Page(s): 564 - 568
05/01/2011 Authors: Factor SA; Steenland NK; Higgins DS; Molho ES; Kay DM; Montimurro J; Rosen AR; Zabetian CP; Payami H -
Movement disorders emergencies. Part 1: Hypokinetic disorders.
Arch Neurol Volume: 68 Page(s): 567 - 572
05/01/2011 Authors: Robottom BJ; Weiner WJ; Factor SA -
LEVO-DOPA (L-DOPA) AND DOPAMINE AGONIST (DA)-NAIVE IDIOPATHIC PARKINSON'S DISEASE (PD) PATIENTS DEMONSTRATE MAINTENANCE OF WAKEFULNESS TEST (MWT)-DEFINED ALERTNESS
Volume: 34 Page(s): A220 - A221
01/01/2011 Authors: Bliwise DL; Trotti L; Wilson A; Greer S; Juncos J; Rye DB; Factor SA; Freeman A; Hollars S; Wood-Siverio C -
Adult-onset dystonia.
Handb Clin Neurol Volume: 100 Page(s): 481 - 511
01/01/2011 Authors: Evatt ML; Freeman A; Factor S -
DIFFERENTIAL ASSOCIATIONS BETWEEN LEVO-DOPA (L-DOPA) VS DOPAMINE AGONIST (DA) DOSE AND MAINTENANCE OF WAKEFULNESS TEST (MWT) MEASURES OF ALERTNESS IN IDIOPATHIC PARKINSON'S DISEASE (PD)
Volume: 34 Page(s): A221 - A221
01/01/2011 Authors: Bliwise DL; Trotti L; Wilson A; Greer S; Juncos J; Rye DB; Factor SA; Freeman A; Hollars S; Wood-Siverio C -
Estimating the half-lives of PCB congeners in former capacitor workers measured over a 28-year interval.
J Expo Sci Environ Epidemiol Volume: 21 Page(s): 234 - 246
01/01/2011 Authors: Seegal RF; Fitzgerald EF; Hills EA; Wolff MS; Haase RF; Todd AC; Parsons P; Molho ES; Higgins DS; Factor SA -
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
PLoS One Volume: 6 Page(s): e27109
01/01/2011 Authors: Hill-Burns EM; Factor SA; Zabetian CP; Thomson G; Payami H -
Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.
Neurobiol Dis Volume: 40 Page(s): 531 - 543
12/01/2010 Authors: Soneson C; Fontes M; Zhou Y; Denisov V; Paulsen JS; Kirik D; Petersn A; Huntington Study Group PREDICT-HD investigators -
Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.
Neurology Volume: 75 Page(s): 2021 - 2027
11/30/2010 Authors: Cheng EM; Tonn S; Swain-Eng R; Factor SA; Weiner WJ; Bever CT; American Academy of Neurology Parkinson Disease Measure Development Panel -
Challenges assessing clinical endpoints in early Huntington disease.
Mov Disord Volume: 25 Page(s): 2595 - 2603
11/15/2010 Authors: Paulsen JS; Wang C; Duff K; Barker R; Nance M; Beglinger L; Moser D; Williams JK; Simpson S; Langbehn D -
SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
Arch Neurol Volume: 67 Page(s): 1350 - 1356
11/01/2010 Authors: Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS -
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.
Neurology Volume: 75 Page(s): 1189 - 1194
09/28/2010 Authors: Kay DM; Stevens CF; Hamza TH; Montimurro JS; Zabetian CP; Factor SA; Samii A; Griffith A; Roberts JW; Molho ES -
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.
Nat Genet Volume: 42 Page(s): 781 - 785
09/01/2010 Authors: Hamza TH; Zabetian CP; Tenesa A; Laederach A; Montimurro J; Yearout D; Kay DM; Doheny KF; Paschall J; Pugh E -
Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy.
Parkinsonism Relat Disord Volume: 16 Page(s): 438 - 441
08/01/2010 Authors: Esper CD; Freeman A; Factor SA -
A long-term study of istradefylline in subjects with fluctuating Parkinson's disease.
Parkinsonism Relat Disord Volume: 16 Page(s): 423 - 426
07/01/2010 Authors: Factor S; Mark MH; Watts R; Struck L; Mori A; Ballerini R; Sussman NM; Istradefylline 6002-US-007 Study Group -
Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: a beta-CIT imaging study.
Neurobiol Dis Volume: 38 Page(s): 219 - 225
05/01/2010 Authors: Seegal RF; Marek KL; Seibyl JP; Jennings DL; Molho ES; Higgins DS; Factor SA; Fitzgerald EF; Hills EA; Korrick SA -
Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics.
Parkinsonism Relat Disord Volume: 16 Page(s): 177 - 180
03/01/2010 Authors: Sollinger AB; Goldstein FC; Lah JJ; Levey AI; Factor SA -
A randomized, placebo-controlled trial of latrepirdine in Huntington disease.
Arch Neurol Volume: 67 Page(s): 154 - 160
02/01/2010 Authors: Kieburtz K; McDermott MP; Voss TS; Corey-Bloom J; Deuel LM; Dorsey ER; Factor S; Geschwind MD; Hodgeman K; Kayson E -
HOUR-TO-HOUR FLUCTUATIONS IN DIGIT SPAN (DS) PERFORMANCE IN PARKINSON'S DISEASE (PD): RELATION TO MWT-DEFINED ALERTNESS
SLEEP Volume: 33 Page(s): A282 - A282
01/01/2010 Authors: Wilson A; Hollars S; Greer S; Trotti L; Juncos J; Factor SA; Freeman A; Wood-Siverio C; Rye DB; Bliwise DL -
Quality of life in Parkinson's disease patients following adjunctive tolcapone therapy: results of an open-label, multicenter, community-based trial.
CNS Spectr Volume: 15 Page(s): 27 - 32
01/01/2010 Authors: Sethi K; Factor S; Watts R -
ORTHOSTASIS ACROSS PARKINSONIAN SYNDROMES ASSOCIATED WITH LOWER MWT-DEFINED ALERTNESS
SLEEP Volume: 33 Page(s): A281 - A282
01/01/2010 Authors: Bliwise DL; Wilson A; Hollars S; Greer S; Trotti L; Juncos J; Factor SA; Freeman A; Wood-Siverio C; Rye DB -
MWT, BUT NOT IMPAIRED OLFACTION, DIFFERENTIATES PARKINSON'S DISEASE (PD) FROM IDIOPATHIC REM BEHAVIOR DISORDER (RBD)
SLEEP Volume: 33 Page(s): A274 - A274
01/01/2010 Authors: Trotti L; Juncos J; Factor SA; Freeman A; Wilson A; Hollars S; Greer S; Wood-Siverio C; Rye DB; Bliwise DL -
Visualizing disease associations: graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and Parkinson's disease.
Genet Epidemiol Volume: 34 Page(s): 92 - 99
01/01/2010 Authors: Payami H; Kay DM; Zabetian CP; Schellenberg GD; Factor SA; McCulloch CC -
Excessive daytime sleepiness in cervical dystonia.
Parkinsonism Relat Disord Volume: 15 Page(s): 784 - 786
12/01/2009 Authors: Trotti LM; Esper CD; Feustel PJ; Bliwise DL; Factor SA -
Occupation and risk of parkinsonism: a multicenter case-control study.
Arch Neurol Volume: 66 Page(s): 1106 - 1113
09/01/2009 Authors: Tanner CM; Ross GW; Jewell SA; Hauser RA; Jankovic J; Factor SA; Bressman S; Deligtisch A; Marras C; Lyons KE -
Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment status.
Mov Disord Volume: 24 Page(s): 1384 - 1387
07/15/2009 Authors: Molho ES; Agarwal N; Regan K; Higgins DS; Factor SA -
Tardive dyskinesia due to aripiprazole: report of 2 cases.
J Clin Psychopharmacol Volume: 29 Page(s): 185 - 186
04/01/2009 Authors: Lungu C; Aia PG; Shih LC; Esper CD; Factor SA; Tarsy D -
Initiating therapy in Parkinson's disease.
Ann Neurol Volume: 65 Page(s): 480 - 481
04/01/2009 Authors: Weiner W; Ahlskog E; Factor S; Suchowersky O; Reich S -
EXCESSIVE DAYTIME SLEEPINESS IN CERVICAL DYSTONIA
Volume: 32 Page(s): A316 - A316
01/01/2009 Authors: Trotti L; Esper CD; Feustel PJ; Bliwise DL; Factor SA -
Genetic association between alpha-synuclein and idiopathic Parkinson's disease.
Am J Med Genet B Neuropsychiatr Genet Volume: 147B Page(s): 1222 - 1230
10/05/2008 Authors: Kay DM; Factor SA; Samii A; Higgins DS; Griffith A; Roberts JW; Leis BC; Nutt JG; Montimurro JS; Keefe RG -
Mild cognitive impairment in Parkinson's disease: Clinical and motor characteristics
Volume: 23 Page(s): 686 - 686
10/01/2008 Authors: Sollinger AB; Goldstein F; Lah J; Levey A; Factor S -
Advanced therapies for movement disorders in neurotherapeutics.
Neurotherapeutics Volume: 5 Page(s): 163
04/01/2008 Authors: Delong MR; Factor SA -
Exploring gene-environment interactions in Parkinson's disease.
Hum Genet Volume: 123 Page(s): 257 - 265
04/01/2008 Authors: McCulloch CC; Kay DM; Factor SA; Samii A; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Montimurro JS -
Current status of symptomatic medical therapy in Parkinson's disease.
Neurotherapeutics Volume: 5 Page(s): 164 - 180
04/01/2008 Authors: Factor SA -
Failure of recognition of drug-induced parkinsonism in the elderly.
Mov Disord Volume: 23 Page(s): 401 - 404
02/15/2008 Authors: Esper CD; Factor SA -
Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease.
Eur J Neurol Volume: 15 Page(s): 134 - 139
02/01/2008 Authors: Hutter CM; Samii A; Factor SA; Nutt JG; Higgins DS; Bird TD; Griffith A; Roberts JW; Leis BC; Montimurro JS -
Aripiprazole associated movement disorders
Volume: 23 Page(s): S239 - S239
01/01/2008 Authors: Aia PG; Esper CD; Juncos JL; Factor SA -
The clinical spectrum of freezing of gait in atypical parkinsonism.
Mov Disord Volume: 23 Suppl 2 Page(s): S431 - S438
01/01/2008 Authors: Factor SA -
Freezing of gait in primary lateral sclerosis
Volume: 23 Page(s): S264 - S264
01/01/2008 Authors: Aia PG; Glass JD; Factor SA -
Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk.
Mov Disord Volume: 23 Page(s): 88 - 95
01/01/2008 Authors: Powers KM; Kay DM; Factor SA; Zabetian CP; Higgins DS; Samii A; Nutt JG; Griffith A; Leis B; Roberts JW -
Clinical and genetic predictors of freezing of gait and falling in Parkinson's disease (PD)
Volume: 23 Page(s): S44 - S44
01/01/2008 Authors: Factor SA; Steenland NK; Higgins DS; Molho ES; Montimurro JS; Rosen AR; Kay DM; Zabetian CP; Payami H -
A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
Clin Neuropharmacol Volume: 31 Page(s): 127 - 133
01/01/2008 Authors: Frank S; Ondo W; Fahn S; Hunter C; Oakes D; Plumb S; Marshall F; Shoulson I; Eberly S; Walker F -
Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history.
Neurogenetics Volume: 8 Page(s): 263 - 270
11/01/2007 Authors: Rosen AR; Steenland NK; Hanfelt J; Factor SA; Lah JJ; Levey AI -
Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys.
J Pharmacol Exp Ther Volume: 323 Page(s): 318 - 326
10/01/2007 Authors: Cao X; Liang L; Hadcock JR; Iredale PA; Griffith DA; Menniti FS; Factor S; Greenamyre JT; Papa SM -
HFE variants C282Y and H63D do not alter risk of Parkinson's disease
Volume: 22 Page(s): XII - XII
09/15/2007 Authors: Kim HM; Samii A; Factor SA; Griffith A; Roberts J; Mosley AD; Leis BC; Yearout D; Hutter CM; Edwards KL -
Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk
Volume: 22 Page(s): II - II
09/15/2007 Authors: Powers KM; Kay DM; Factor SA; Zabetian CP; Higgins D; Samii A; Nutt JG; Griffith A; Leis B; Roberts JW -
Multi-center trial of Tasmar in Parkinson's disease: Real-world experience
Volume: 22 Page(s): XV - XVI
09/15/2007 Authors: Sethi K; Factor S; Watts R -
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
Ann Neurol Volume: 62 Page(s): 137 - 144
08/01/2007 Authors: Zabetian CP; Hutter CM; Factor SA; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Kay DM; Yearout D -
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group.
Mov Disord Volume: 22 Page(s): 1061 - 1068
06/15/2007 Authors: Ravina B; Marder K; Fernandez HH; Friedman JH; McDonald W; Murphy D; Aarsland D; Babcock D; Cummings J; Endicott J -
Predictors of diagnosis in Huntington disease.
Neurology Volume: 68 Page(s): 1710 - 1717
05/15/2007 Authors: Langbehn DR; Paulsen JS; Huntington Study Group -
Current and future treatments in multiple system atrophy.
Curr Treat Options Neurol Volume: 9 Page(s): 210 - 223
05/01/2007 Authors: Esper CD; Factor SA -
Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease.
Neurology Volume: 68 Page(s): 1108 - 1115
04/03/2007 Authors: Pahwa R; Stacy MA; Factor SA; Lyons KE; Stocchi F; Hersh BP; Elmer LW; Truong DD; Earl NL; EASE-PD Adjunct Study Investigators -
Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease.
Curr Med Res Opin Volume: 23 Page(s): 741 - 750
04/01/2007 Authors: Lew MF; Pahwa R; Leehey M; Bertoni J; Kricorian G; Zydis Selegiline Study Group -
Ropinirole 24-hour prolonged release as an adjunct to L-dopa improves motor function and activities of daily living in advanced Parkinson's disease.
Volume: 55 Page(s): S157 - S157
04/01/2007 Authors: Stover NP; Pahwa R; Factor S; Earl NL -
Oromandibular and lingual dystonia: Etiology and treatment with botulinum toxin
Volume: 68 Page(s): A381 - A381
03/20/2007 Authors: Esper CD; Factor SA -
Cervical dystonia: A pilot assessment of sleepiness and fatigue
Volume: 68 Page(s): A381 - A381
03/20/2007 Authors: Esper CD; Feustel PJ; Factor SA -
R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation.
Mov Disord Volume: 22 Page(s): 254 - 257
01/15/2007 Authors: Nichols WC; Marek DK; Pauciulo MW; Pankratz N; Halter CA; Rudolph A; Shults CW; Wojcieszek J; Foroud T; Parkinson Study Group - PROGENI Investigators -
Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.
Ann Neurol Volume: 61 Page(s): 47 - 54
01/01/2007 Authors: Kay DM; Moran D; Moses L; Poorkaj P; Zabetian CP; Nutt J; Factor SA; Yu C-E; Montimurro JS; Keefe RG -
Fatal Parkinsonism-hyperpyrexia syndrome in a Parkinson's disease patient while actively treated with deep brain stimulation.
Mov Disord Volume: 22 Page(s): 148 - 149
01/01/2007 Authors: Factor SA -
Progressive supranuclear palsy.
Rev Neurol Dis Volume: 4 Page(s): 209 - 216
01/01/2007 Authors: Esper CD; Weiner WJ; Factor SA -
Entacapone to tolcapone switch: Multicenter double-blind, randomized, active-controlled trial in advanced Parkinson's disease.
Mov Disord Volume: 22 Page(s): 14 - 19
01/01/2007 Authors: Entacapone to Tolcapone Switch Study Investigators -
Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.
Mov Disord Volume: 21 Page(s): 2257 - 2260
12/01/2006 Authors: Pankratz N; Pauciulo MW; Elsaesser VE; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T; Nichols WC; Parkinson Study Group-PROGENI Investigators -
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
Mov Disord Volume: 21 Page(s): 2078 - 2081
12/01/2006 Authors: Friedman JH; Berman RM; Goetz CG; Factor SA; Ondo WG; Wojcieszek J; Carson WH; Marcus RN -
Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.
Lancet Neurol Volume: 5 Page(s): 917 - 923
11/01/2006 Authors: Elbaz A; Nelson LM; Payami H; Ioannidis JPA; Fiske BK; Annesi G; Carmine Belin A; Factor SA; Ferrarese C; Hadjigeorgiou GM -
LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.
Am J Hum Genet Volume: 79 Page(s): 752 - 758
10/01/2006 Authors: Zabetian CP; Hutter CM; Yearout D; Lopez AN; Factor SA; Griffith A; Leis BC; Bird TD; Nutt JG; Higgins DS -
Drug-induced parkinsonism: Still common, under-recognized, and treatable
Volume: 21 Page(s): 1554 - 1554
09/01/2006 Authors: Esper CD; Factor SA -
Ropinirole 24-hour prolonged release reduces 'off' time in patients with Parkinson's disease not optimally controlled with L-dopa
EUROPEAN JOURNAL OF NEUROLOGY Volume: 13 Page(s): 209 - 209
09/01/2006 Authors: Pahwa R; Factor SA; Elmer LW -
Essential tremor phenotyping and molecular genetics: ET database cases and a new large pedigree
Volume: 21 Page(s): 1556 - 1556
09/01/2006 Authors: Rosen AR; Levey AI; Bouzyk M; Wichmann T; Factor SA; Testa CM -
Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology Volume: 66 Page(s): 983 - 995
04/11/2006 Authors: Pahwa R; Factor SA; Lyons KE; Ondo WG; Gronseth G; Bronte-Stewart H; Hallett M; Miyasaki J; Stevens J; Weiner WJ -
Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.
Mov Disord Volume: 21 Page(s): 519 - 523
04/01/2006 Authors: Kay DM; Zabetian CP; Factor SA; Nutt JG; Samii A; Griffith A; Bird TD; Kramer P; Higgins DS; Payami H -
Primary progressive freezing gait: a syndrome with many causes.
Neurology Volume: 66 Page(s): 411 - 414
02/14/2006 Authors: Factor SA; Higgins DS; Qian J -
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
Neurology Volume: 66 Page(s): 366 - 372
02/14/2006 Authors: Huntington Study Group -
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.
Arch Neurol Volume: 63 Page(s): 210 - 216
02/01/2006 Authors: Blindauer K; Shoulson I; Oakes D; Kieburtz K; Schwid S; Fahn S; Stern M; Goetz C; Nutt J; Goren S -
Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression.
J Neuroinflammation Volume: 3 Page(s): 1
01/20/2006 Authors: Huber VC; Mondal T; Factor SA; Seegal RF; Lawrence DA -
Drug-induced parkinsonism: Still common, under-recognized, and treatable
Volume: 60 Page(s): S75 - S75
01/01/2006 Authors: Esper CD; Factor SA -
Essential tremor phenotyping and molecular genetics: Database cases and a new large pedigree
Volume: 21 Page(s): S405 - S405
01/01/2006 Authors: Testa CM; Rosen AR; Wichmann T; Levey AI; Bouzyk M; Factor SA -
Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
Mov Disord Volume: 21 Page(s): 45 - 49
01/01/2006 Authors: Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC -
Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease.
Genet Test Volume: 10 Page(s): 221 - 227
01/01/2006 Authors: Kay DM; Bird TD; Zabetian CP; Factor SA; Samii A; Higgins DS; Nutt J; Roberts JW; Griffith A; Leis BC -
Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases.
J Clin Neurosci Volume: 12 Page(s): 941 - 945
11/01/2005 Authors: Murphy MA; Friedman JH; Tetrud JW; Factor SA -
A randomized, double-blind, placebo-controlled, staggered withdrawal study in patients with Huntington's disease treated with tetrabenazine
Volume: 20 Page(s): 1244 - 1244
09/01/2005 Authors: Frank S; Ondo W; Hunter C; Marshall F; Walker F; Eberly S; Factor S; Fahn S; Hunt V; Oakes D -
Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
Mov Disord Volume: 20 Page(s): 1152 - 1160
09/01/2005 Authors: Factor SA; Molho ES; Evans S; Feustel PJ -
Interrater agreement in the assessment of motor manifestations of Huntington's disease.
Mov Disord Volume: 20 Page(s): 293 - 297
03/01/2005 Authors: Hogarth P; Kayson E; Kieburtz K; Marder K; Oakes D; Rosas D; Shoulson I; Wexler NS; Young AB; Zhao H -
False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy.
Ann Neurol Volume: 57 Page(s): 462 - 463
03/01/2005 Authors: Factor SA; Qian J; Lava NS; Hubbard JD; Payami H -
Levodopa and the progression of Parkinson's disease.
N Engl J Med Volume: 351 Page(s): 2498 - 2508
12/09/2004 Authors: Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K; Parkinson Study Group -
Diabetes mellitus among parkinsonian patients treated chronically with clozapine.
Parkinsonism Relat Disord Volume: 10 Page(s): 439 - 441
10/01/2004 Authors: Fernandez HH; Friedman JH; Lansang MC; Factor SA; Molho ES; Coskun DJ -
Efficacy and safety of repeated doses of botulinum toxin type B in type a resistant and responsive cervical dystonia patients.
Volume: 19 Page(s): 1122 - 1123
09/01/2004 Authors: Factor SA; Molho ES; Evans S; Feustel PJ -
Biological bases for PCB induced alterations in dopamine-mediated neurological function.
Volume: 25 Page(s): 703 - 703
06/01/2004 Authors: Seegal RF; Marek KL; Factor SA; McCaffrey RJ; Haase RF; Kanthasamy AG -
Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease.
Mov Disord Volume: 19 Page(s): 649 - 655
06/01/2004 Authors: Nichols WC; Uniacke SK; Pankratz N; Reed T; Simon DK; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T -
Literature review: intermittent subcutaneous apomorphine therapy in Parkinson's disease.
Neurology Volume: 62 Page(s): S12 - S17
03/23/2004 Authors: Factor SA -
Threatening auditory hallucinations and Cotard syndrome in Parkinson disease.
Clin Neuropharmacol Volume: 27 Page(s): 205 - 207
01/01/2004 Authors: Factor SA; Molho ES -
Dystonia in AIDS: report of four cases.
Mov Disord Volume: 18 Page(s): 1492 - 1498
12/01/2003 Authors: Factor SA; Troche-Panetto M; Weaver SA -
Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families.
Hum Mol Genet Volume: 12 Page(s): 2599 - 2608
10/15/2003 Authors: Pankratz N; Nichols WC; Uniacke SK; Halter C; Murrell J; Rudolph A; Shults CW; Conneally PM; Foroud T; Parkinson Study Group -
Neuropathology in a patient with ataxia and the SCA8 genotype
Volume: 18 Page(s): 1095 - 1095
09/01/2003 Authors: Factor SA; Qian J; Lava NS -
Longitudinal outcome of Parkinson's disease patients with psychosis.
Neurology Volume: 60 Page(s): 1756 - 1761
06/10/2003 Authors: Factor SA; Feustel PJ; Friedman JH; Comella CL; Goetz CG; Kurlan R; Parsa M; Pfeiffer R; Parkinson Study Group -
Significant linkage of Parkinson disease to chromosome 2q36-37.
Am J Hum Genet Volume: 72 Page(s): 1053 - 1057
04/01/2003 Authors: Pankratz N; Nichols WC; Uniacke SK; Halter C; Rudolph A; Shults C; Conneally PM; Foroud T; Parkinson Study Group -
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease.
Neurology Volume: 60 Page(s): 796 - 801
03/11/2003 Authors: Foroud T; Uniacke SK; Liu L; Pankratz N; Rudolph A; Halter C; Shults C; Marder K; Conneally PM; Nichols WC -
The natural history of the syndrome of primary progressive freezing gait.
Arch Neurol Volume: 59 Page(s): 1778 - 1783
11/01/2002 Authors: Factor SA; Jennings DL; Molho ES; Marek KL -
Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.
Emerg Infect Dis Volume: 8 Page(s): 1124 - 1132
10/01/2002 Authors: Shepard CW; Soriano-Gabarro M; Zell ER; Hayslett J; Lukacs S; Goldstein S; Factor S; Jones J; Ridzon R; Williams I -
Cervical dystonia in twins.
Mov Disord Volume: 17 Page(s): 846 - 847
07/01/2002 Authors: Factor SA -
The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
Mov Disord Volume: 17 Page(s): 676 - 681
07/01/2002 Authors: Reddy S; Factor SA; Molho ES; Feustel PJ -
Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.
Am J Hum Genet Volume: 71 Page(s): 124 - 135
07/01/2002 Authors: Pankratz N; Nichols WC; Uniacke SK; Halter C; Rudolph A; Shults C; Conneally PM; Foroud T; Parkinson Study Group -
Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease families.
J Med Genet Volume: 39 Page(s): 489 - 492
07/01/2002 Authors: Nichols WC; Pankratz N; Uniacke SK; Pauciulo MW; Halter C; Rudolph A; Conneally PM; Foroud T -
Pharmacology of atypical antipsychotics.
Clin Neuropharmacol Volume: 25 Page(s): 153 - 157
01/01/2002 Authors: Factor SA -
Risperidone and Parkinson's disease.
Mov Disord Volume: 17 Page(s): 221 - 222
01/01/2002 Authors: Factor SA; Molho ES; Friedman JH -
Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
Mov Disord Volume: 17 Page(s): 158 - 161
01/01/2002 Authors: Adler CH; Factor SA; Brin M; Sethi KD -
Parkinson's Disease: Initial Treatment with Levodopa or Dopamine Agonists.
Curr Treat Options Neurol Volume: 3 Page(s): 479 - 493
11/01/2001 Authors: Factor SA -
Cervical dystonia severity scale reliability study.
Mov Disord Volume: 16 Page(s): 1086 - 1090
11/01/2001 Authors: O'Brien C; Brashear A; Cullis P; Truong D; Molho E; Jenkins S; Wojcieszek J; O'Neil T; Factor S; Seeberger L -
A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events.
Arch Neurol Volume: 58 Page(s): 1385 - 1392
09/01/2001 Authors: Dewey RB; Hutton JT; LeWitt PA; Factor SA -
The natural history of embouchure dystonia.
Mov Disord Volume: 16 Page(s): 899 - 906
09/01/2001 Authors: Frucht SJ; Fahn S; Greene PE; O'Brien C; Gelb M; Truong DD; Welsh J; Factor S; Ford B -
Focal myopathy as a cause of anterocollis in Parkinsonism.
Mov Disord Volume: 16 Page(s): 754 - 756
07/01/2001 Authors: Lava NS; Factor SA -
Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.
Curr Neurol Neurosci Rep Volume: 1 Page(s): 320 - 328
07/01/2001 Authors: Molho ES; Factor SA -
The long-term safety and efficacy of pramipexole in advanced Parkinson's disease.
Parkinsonism Relat Disord Volume: 7 Page(s): 115 - 120
04/01/2001 Authors: Weiner WJ; Factor SA; Jankovic J; Hauser RA; Tetrud JW; Waters CH; Shulman LM; Glassman PM; Beck B; Paume D -
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.
Neurology Volume: 56 Page(s): 455 - 462
02/27/2001 Authors: Shoulson I; Penney J; McDermott M; Schwid S; Kayson E; Chase T; Fahn S; Greenamyre JT; Lang A; Siderowf A -
Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial.
Mov Disord Volume: 16 Page(s): 135 - 139
01/01/2001 Authors: Factor SA; Friedman JH; Lannon MC; Oakes D; Bourgeois K; Parkinson Study Group -
Long-term comparative experience with tolcapone and entacapone in advanced Parkinson's disease.
Clin Neuropharmacol Volume: 24 Page(s): 295 - 299
01/01/2001 Authors: Factor SA; Molho ES; Feustel PJ; Brown DL; Evans SM -
An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy.
Neurology Volume: 55 Page(s): 1364 - 1367
11/14/2000 Authors: Higgins JJ; Golbe LI; De Biase A; Jankovic J; Factor SA; Adler RL -
Atypical antipsychotics: clozapine-related cardiac complications.
Mov Disord Volume: 15 Page(s): 1300
11/01/2000 Authors: Serrano-Dueas M -
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
JAMA Volume: 284 Page(s): 1931 - 1938
10/18/2000 Authors: Parkinson Study Group -
Ropinirole as compared with levodopa in Parkinson's disease.
N Engl J Med Volume: 343 Page(s): 884
09/21/2000 Authors: Yamamoto T -
Ropinirole as compared with levodopa in Parkinson's disease.
N Engl J Med Volume: 343 Page(s): 885
09/21/2000 Authors: Weiner WJ; Factor SA -
Current and emerging treatments for cervical dystonia.
CNS Spectr Volume: 5 Page(s): S1 - S8
06/01/2000 Authors: Factor SA; Lew MF; Trosch RM -
The initial treatment of Parkinson's disease.
Mov Disord Volume: 15 Page(s): 360 - 361
03/01/2000 Authors: Factor SA -
Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
Mov Disord Volume: 15 Page(s): 201 - 211
03/01/2000 Authors: Friedman JH; Factor SA -
Emergency department presentations of patients with Parkinson's disease.
Am J Emerg Med Volume: 18 Page(s): 209 - 215
03/01/2000 Authors: Factor SA; Molho ES -
A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia.
Clin Neuropharmacol Volume: 23 Page(s): 75 - 81
01/01/2000 Authors: Hauser RA; Friedlander J; Zesiewicz TA; Adler CH; Seeberger LC; O'Brien CF; Molho ES; Factor SA -
Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease.
Mov Disord Volume: 15 Page(s): 167 - 169
01/01/2000 Authors: Factor SA; Brown DL; Molho ES -
The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials.
Volume: 55 Page(s): S29 - S35
01/01/2000 Authors: Lew MF; Brashear A; Factor S -
Worsening of motor features of parkinsonism with olanzapine.
Mov Disord Volume: 14 Page(s): 1014 - 1016
11/01/1999 Authors: Molho ES; Factor SA -
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
Mov Disord Volume: 14 Page(s): 911 - 913
11/01/1999 Authors: Agid Y; Ahlskog E; Albanese A; Calne D; Chase T; De Yebenes J; Factor S; Fahn S; Gershanik O; Goetz C -
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
Neurology Volume: 53 Page(s): 1439 - 1446
10/22/1999 Authors: Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ -
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
Neurology Volume: 53 Page(s): 1431 - 1438
10/22/1999 Authors: Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A -
Possible tardive dystonia resulting from clozapine therapy.
Mov Disord Volume: 14 Page(s): 873 - 874
09/01/1999 Authors: Molho ES; Factor SA -
Acute delirium after withdrawal of amantadine in Parkinson's disease.
Neurology Volume: 52 Page(s): 1720 - 1721
05/12/1999 Authors: Miyasaki JM; Grimes D; Lang AE -
Transient benefit of amantadine in Parkinson's disease: the facts about the myth.
Mov Disord Volume: 14 Page(s): 515 - 517
05/01/1999 Authors: Factor SA; Molho ES -
Parkinson's Disease: Motor Fluctuations.
Curr Treat Options Neurol Volume: 1 Page(s): 21 - 32
03/01/1999 Authors: Factor SA -
Dopamine agonists.
Med Clin North Am Volume: 83 Page(s): 415 - vii
03/01/1999 Authors: Factor SA -
Clinical presentation and pharmacological therapy in corticobasal degeneration.
Arch Neurol Volume: 55 Page(s): 957 - 961
07/01/1998 Authors: Kompoliti K; Goetz CG; Boeve BF; Maraganore DM; Ahlskog JE; Marsden CD; Bhatia KP; Greene PE; Przedborski S; Seal EC -
Clinical comparison of tardive and idiopathic cervical dystonia.
Mov Disord Volume: 13 Page(s): 486 - 489
05/01/1998 Authors: Molho ES; Feustel PJ; Factor SA -
Acute delirium after withdrawal of amantadine in Parkinson's disease.
Neurology Volume: 50 Page(s): 1456 - 1458
05/01/1998 Authors: Factor SA; Molho ES; Brown DL -
'Sleep benefit' in Parkinson's disease.
Neurology Volume: 50 Page(s): 1514 - 1515
05/01/1998 Authors: Factor SA; Weiner WJ -
Adult-onset tics associated with peripheral injury.
Mov Disord Volume: 12 Page(s): 1052 - 1055
11/01/1997 Authors: Factor SA; Molho ES -
Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonism.
Mov Disord Volume: 12 Page(s): 783 - 789
09/01/1997 Authors: Factor SA; Barron KD -
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
Neurology Volume: 49 Page(s): 701 - 707
09/01/1997 Authors: Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C -
The emerging role of clozapine in the treatment of movement disorders.
Mov Disord Volume: 12 Page(s): 483 - 496
07/01/1997 Authors: Factor SA; Friedman JH -
Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group.
Neurology Volume: 48 Page(s): 1070 - 1077
04/01/1997 Authors: Richard IH; Kurlan R; Tanner C; Factor S; Hubble J; Suchowersky O; Waters C -
An open-label study of botulinum toxin A for treatment of tardive dystonia.
Clin Neuropharmacol Volume: 20 Page(s): 90 - 93
02/01/1997 Authors: Tarsy D; Kaufman D; Sethi KD; Rivner MH; Molho E; Factor S -
Chorea caused by lithium intoxication: a case report and literature review.
Mov Disord Volume: 11 Page(s): 733 - 737
11/01/1996 Authors: Podskalny GD; Factor SA -
The effect of dancing on dystonia.
Mov Disord Volume: 11 Page(s): 225 - 227
03/01/1996 Authors: Molho ES; Factor SA; Podskalny GD; Brown D -
Psychogenic movement disorders: frequency, clinical profile, and characteristics.
J Neurol Neurosurg Psychiatry Volume: 59 Page(s): 406 - 412
10/01/1995 Authors: Factor SA; Podskalny GD; Molho ES -
Pergolide in the treatment of Parkinson's disease.
Neurology Volume: 45 Page(s): S13 - S21
03/01/1995 Authors: Mizuno Y; Kondo T; Narabayashi H -
Peripheral catecholamine output in Parkinson's disease: effects of drug treatment.
Exp Neurol Volume: 131 Page(s): 64 - 68
01/01/1995 Authors: Factor SA; Schneider AS -
The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease.
J Neural Transm Suppl Volume: 45 Page(s): 225 - 230
01/01/1995 Authors: Molho ES; Factor SA; Weiner WJ; Sanchez-Ramos JR; Singer C; Shulman L; Brown D; Sheldon C -
Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
J Neuropsychiatry Clin Neurosci Volume: 7 Page(s): 304 - 307
01/01/1995 Authors: Factor SA; Molho ES; Brown DL -
Parkinson's disease: drug-induced psychiatric states.
Adv Neurol Volume: 65 Page(s): 115 - 138
01/01/1995 Authors: Factor SA; Molho ES; Podskalny GD; Brown D -
Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report.
J Neurol Sci Volume: 127 Page(s): 114 - 120
12/01/1994 Authors: Factor SA; Podskalny GD; Barron KD -
The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group.
Ann Neurol Volume: 35 Page(s): 717 - 723
06/01/1994 Authors: Koller WC; Busenbark K; Miner K -
Platelet morphology in Parkinson's disease: an electron microscopic study.
J Neurol Sci Volume: 122 Page(s): 84 - 89
03/01/1994 Authors: Factor SA; Ortof E; Dentinger MP; Mankes R; Barron KD -
Clozapine: a 2-year open trial in Parkinson's disease patients with psychosis.
Neurology Volume: 44 Page(s): 544 - 546
03/01/1994 Authors: Factor SA; Brown D; Molho ES; Podskalny GD -
Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
Mov Disord Volume: 8 Page(s): 257 - 262
07/01/1993 Authors: Factor SA; Weiner WJ -
Basal ganglia infarction as a possible cause of cervical dystonia.
Mov Disord Volume: 8 Page(s): 213 - 216
04/01/1993 Authors: Molho ES; Factor SA -
Acetazolamide therapy of menstrual-related fluctuations in Parkinson's disease.
Mov Disord Volume: 8 Page(s): 240 - 241
04/01/1993 Authors: Factor SA -
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease.
Neurology Volume: 43 Page(s): 21 - 27
01/01/1993 Authors: Weiner WJ; Factor SA; Sanchez-Ramos JR; Singer C; Sheldon C; Cornelius L; Ingenito A -
Clozapine prevents recurrence of psychosis in Parkinson's disease.
Mov Disord Volume: 7 Page(s): 125 - 131
01/01/1992 Authors: Factor SA; Brown D -
Paroxysmal tremor and orofacial dyskinesia secondary to a biopterin synthesis defect.
Neurology Volume: 41 Page(s): 930 - 932
06/01/1991 Authors: Factor SA; Coni RJ; Cowger M; Rosenblum EL -
Persistent extrapyramidal syndrome with dystonia and rigidity caused by combined metoclopramide and prochlorperazine therapy.
South Med J Volume: 84 Page(s): 626 - 628
05/01/1991 Authors: Factor SA; Matthews MK -
Focal dystonia secondary to cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome.
Mov Disord Volume: 6 Page(s): 69 - 72
01/01/1991 Authors: Tolge CF; Factor SA -
Prior history of head trauma in Parkinson's disease.
Mov Disord Volume: 6 Page(s): 225 - 229
01/01/1991 Authors: Factor SA; Weiner WJ -
SPASMODIC TORTICOLLIS SECONDARY TO BASAL GANGLIA INFARCTION
MOVEMENT DISORDERS Volume: 6 Page(s): 274 - 275
01/01/1991 Authors: MOLHO E; FACTOR SA -
CLINICAL VARIATIONS OF TREMOR IN PARKINSONS-DISEASE
MOVEMENT DISORDERS Volume: 6 Page(s): 276 - 276
01/01/1991 Authors: FACTOR SA; BROWN D -
Sleep disorders and sleep effect in Parkinson's disease.
Mov Disord Volume: 5 Page(s): 280 - 285
01/01/1990 Authors: Factor SA; McAlarney T; Sanchez-Ramos JR; Weiner WJ -
Vitamin E therapy in Parkinson's disease.
Adv Neurol Volume: 53 Page(s): 457 - 461
01/01/1990 Authors: Factor SA; Sanchez-Ramos JR; Weiner WJ -
HEAD TREMOR AFTER A REMISSION OF SPASMODIC TORTICOLLIS
MOVEMENT DISORDERS Volume: 5 Page(s): 354 - 354
01/01/1990 Authors: FACTOR SA -
Head tremor after a remission of spasmodic torticollis.
Mov Disord Volume: 5 Page(s): 353 - 354
01/01/1990 Authors: Factor SA -
Acetaminophen metabolism by cytochrome P450 monooxygenases in Parkinson's disease.
Ann Neurol Volume: 26 Page(s): 286 - 288
08/01/1989 Authors: Factor SA; Weiner WJ; Hefti F -
Psychogenic tremors.
Neurology Volume: 39 Page(s): 1094 - 1099
08/01/1989 Authors: Koller W; Lang A; Vetere-Overfield B; Findley L; Cleeves L; Factor S; Singer C; Weiner W -
The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's disease.
J Neurol Neurosurg Psychiatry Volume: 52 Page(s): 732 - 735
06/01/1989 Authors: Weiner WJ; Factor SA; Sanchez-Ramos JR -
Trauma as an etiologic agent in Parkinson disease.
Mov Disord Volume: 4 Page(s): 90 - 92
01/01/1989 Authors: Jellinger K -
Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis.
Mov Disord Volume: 4 Page(s): 266 - 273
01/01/1989 Authors: Sanchez-Ramos JR; Factor SA; Weiner WJ; Marquez J -
Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease.
J Neurol Neurosurg Psychiatry Volume: 52 Page(s): 83 - 88
01/01/1989 Authors: Factor SA; Sanchez-Ramos JR; Weiner WJ; Ingenito AM -
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.
J Neurol Neurosurg Psychiatry Volume: 51 Page(s): 529 - 533
04/01/1988 Authors: Factor SA; Sanchez-Ramos JR; Weiner WJ -
Cocaine and Tourette's syndrome.
Ann Neurol Volume: 23 Page(s): 423 - 424
04/01/1988 Authors: Factor SA; Sanchez-Ramos JR; Weiner WJ -
Delayed-onset dystonia associated with corticospinal tract dysfunction.
Mov Disord Volume: 3 Page(s): 201 - 210
01/01/1988 Authors: Factor SA; Sanchez-Ramos J; Weiner WJ -
Trauma as an etiology of parkinsonism: a historical review of the concept.
Mov Disord Volume: 3 Page(s): 30 - 36
01/01/1988 Authors: Factor SA; Sanchez-Ramos J; Weiner WJ -
Adrenal grafts for Parkinson's disease.
N Engl J Med Volume: 317 Page(s): 1091 - 1093
10/22/1987 -
Early brain-stem auditory evoked responses in vertebrobasilar transient ischemic attacks.
Arch Neurol Volume: 44 Page(s): 544 - 547
05/01/1987 Authors: Factor SA; Dentinger MP -
Ethylene glycol intoxication: a new stage in the clinical syndrome.
N Y State J Med Volume: 87 Page(s): 179 - 180
03/01/1987 Authors: Factor SA; Lava NS -
A double-blind evaluation of ciladopa in Parkinson's disease.
Mov Disord Volume: 2 Page(s): 211 - 217
01/01/1987 Authors: Weiner WJ; Factor SA; Sanchez-Ramos J; Berger J